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ABSTRACT 
 
The prevalence of Brucella canis in South Africa is unknown and suspected to be under-
detected. The majority of dogs in South Africa are not tested for Brucella canis, not only 
because of the level of awareness of Brucella canis in South Africa, but also because of the 
lack of clinical suspicion. It is not known how the infection entered South Africa. 
 
Brucella canis, a zoonotic organism that causes canine brucellosis in dogs, is a significant 
cause of reproductive failure in dogs worldwide. Canine brucellosis is a chronic infectious 
zoonotic disease whose main etiological agent, the Brucella canis bacterium, are rough, 
intracellular proteobacteria in the Brucellaceae family. Clinical signs in bitches are mainly 
infertility and abortion, while in males, epididymitis and orchitis occur. However, 
discospondylitis may develop in both sexes. 
 
A serological survey was conducted to determine the prevalence of Brucella canis infection 
in dogs from the Nelson Mandela Bay Metropolitan (NMBM) Port Elizabeth (PE) area. A 
total of 400 samples were collected, 350 of which were collected in seven different 
townships and 50 were collected in the three different welfare organisations in the study 
area. 
 
Of the 400 serum samples collected, 39 (9.75%) tested serologically positive by using the 
Tube Agglutination Test (TAT), the 2-Mercaptoethanol-TAT (2ME-TAT) or the 
Compliment Fixation Test (CFT). The results of the CFT showed that nine of the 39 positive 
samples had a maximum antibody titre of 784 IU/ml. The prevalence rate varied 
tremendously between the samples from the townships and those from the welfare 
organisations. The prevalence rate of seropositive animals in PE ranged between 5% and 
16% in the study area. No positive cases were found in KwaMagxaki and the Animal 
Welfare Society of PE, but both were surrounded by areas that had positive cases of Brucella 
canis infection. 
 
The female dogs in the study area had a higher sero-prevalence of only 0.0169 (95% CI, 
0.0631 to 0.1489) differences in proportion, and were thus not significant (p > 0.05). 
However, the female spayed dogs had a much higher significant difference of 0.1898 (95% 
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CI, 0.1058 to 0.2738) in proportion to the male neutered dogs and were thus statistically 
significant (p < 0.05). Despite those results, out of all the dogs positive for Brucella canis 
only two were neutered males and five were spayed females, and the rest were all intact. 
 
In conclusion, according to the results, Brucella canis antibodies were detected in sera of 
dogs mostly from the townships surveyed. Preventive measures against this contagion 
should be taken into consideration to eliminate Brucella canis infection from the entire dog 
population. Reservoir dogs and actively infected dogs either should be kept in quarantine or 
should be euthanized, because not only can they spread the disease and end the reproductive 
life of any breeding animal, but they are also a risk to human health. 
 
Even though this is the first survey conducted in the Eastern Cape, the results are still high 
and the bacterium is spreading.  
 
 
Key words 
 
Zoonotic disease; Humans; Abortion; Infertility; Townships; Welfare organisations; 
Serology; TAT; CFT. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Introduction 
Brucellosis is one of the most important infectious zoonotic diseases of animals and man 
caused by several species of bacteria belonging to the genus Brucella (Bengis & Keet, 2003). 
The Brucella canis (B. canis) organism is a small, rough, gram-negative intracellular 
bacterium with wild canids and dogs as its reservoir hosts. In 1963, several outbreaks of 
canine abortion were reported and LE Carmichael identified and isolated B. canis in 1966 
from canine tissue and vaginal discharges (Carmichael, 1966).  
 
Since the first description of Brucellosis, ten species in the genus Brucella (B.) have been 
recognized. They consist of six classical species, namely: B. melitensis (1887), B. abortus 
(1897), B. suis (1914), B. ovis (1952), B. neotomae (1957) and B. canis (1966), and four 
novel species (B. ceti, B. pinnipedialis, B. microti and B. inopinata) infecting terrestrial and 
aquatic animals (Kazmierchak, 2012). 
 
B. canis infection is characterized by abortions in bitches and testicular atrophy, epididymitis 
and infertility in male dogs. Male dogs harbour and transmit the B. canis organism mainly 
through natural mating. Infections may occur after ingestion of infected placental material 
and aborted foetuses. Bitches that are infected with B. canis can also spread the disease 
through vaginal discharges when in heat, after abortion and/or during breeding. The 
organisms may be shed for several weeks, or intermittently for months after an abortion of 
the foetus or pups (Greene & Carmichael, 2006). Clinical signs of infected dogs may go 
unnoticed, and even abortions, stillbirth and infertility can be misleading with regard to the 
disease. 
 
Serology is still the most commonly used method to diagnose Brucella, but must be used in 
combination with more specific methods like the Tube Agglutination Test (TAT) and 
repeated blood culturing is necessary to confirm diagnoses (Keid et al., 2009). Wanke (2004) 
states that the different serological tests differ in sensitivities and specificities, which might 
lead to false positive and negative results, and this necessitates the use of serology in 
combination with bacteriology.  
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Brucellosis is sometimes a very difficult disease to diagnose by means of serology due to 
false positive reactions caused by cross-reactions with other Gram-negative bacteria such as 
Bordetella and Pseudomonas (Centre of Food Security and Public Health (CSFPH), 2012). 
The absence of Brucella antibodies may also be a possibility during the early stages of the 
infection as well as in chronically infected animals. 
 
According to Wanke (2004), blood is the best material to use because it is easy to collect 
and sterile and will allow for uncontaminated cultures. Weber and Christoph (1982) state 
that antibodies against Brucella can be detected at two weeks post infection by means of 
serology. 
 
The CFT is widely used with high test specificity (Poester et al., 2010). The CFT detects the 
presence of specific antibodies in the serum sample. This test is based on the use of a 
compliment, which is a biologically labile serum factor that causes immune cytolysis. When 
there is a formation of antigen-antibody (Ag-Ab) complex, the compliment naturally 
becomes activated (Giri, 2015). 
 
In humans, although infrequent and reported to be rare, infections with B. canis are probably 
more common than indicated in published reports (Lucero et al., 2005). This statement can 
be linked to the disease being misdiagnosed in humans, leading to possible under-reporting. 
In the majority of human case reports, B. canis infection has been related to exposure to 
whelping females when high concentrations of the organism occur in birthing fluids and 
vaginal discharge (Kazmierchak, 2012).  
 
Socio-economic deprivation, as well as the changes in the urban and peri-urban environment 
due to the development of slums and informal communities, has resulted in increased dog 
populations and thus a dramatic increase of canine roamers in these communities (Marzetti 
et al., 2012). Infection acquired through environmental contamination is also possible, 
especially in areas where dogs often urinate or where vaginal discharges are deposited 
(Carmichael & Kenney, 1970). Furthermore, dogs living together are at higher risk of 
infecting each other, with urine being the most important source of infection in these cases, 
especially from male dogs.  
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1.2 Aim 
• To investigate the sero-prevalence of B. canis infection in dogs with sera samples 
obtained from seven townships and three welfare organisations in the PE area and to 
evaluate the results obtained with the serological test.  
• To investigate the general status of dogs in the study area of the NMBM and to 
evaluate the results obtained through the questionnaire.  
 
1.3 Hypothesis 
The prevalence of B. canis in South Africa is unknown and suspected to be under-detected. 
The majority of dogs in South Africa are never tested against B. canis, not only because of 
the level of awareness of B. canis in South Africa, but also because of the lack of clinical 
suspicion, as the bacterium was never present in South Africa. It is also not known how the 
infection entered South Africa (Henton, 2010). 
 
The possibility does exist that stray and uncontrolled dogs originating from different 
locations within South Africa could spread the disease. Uncontrolled and stray dogs from 
townships roam freely, the majority of whose disease status is unknown and unreported. 
This gives rise to the possibility of these dogs spreading these pathogens to other formal and 
informal settlements in the surrounding areas. 
 
Cases of B. canis have already been identified and tested positive for B. canis antibodies in 
the Eastern and Western Cape. If there were already positive cases of B. canis infection 
found in dogs within the NMBM, then there is a possibility that more dogs can be infected 
with B. canis and that the disease has been spreading unknowingly throughout the NMBM. 
 
1.4 Objectives 
• To establish the prevalence of B. canis in the study area of the NMBM 
• To compare the prevalence of B. canis in dogs between the townships 
• To compare the prevalence of B. canis in dogs between the welfare organisations 
• To compare the general status of dogs with regard to the neutered/spayed dogs, 
male/female dogs and the body condition score of all the dogs sampled in the 
NMBM 
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1.5 Research Questions 
• What is the prevalence rate of B. canis in the study area of the NMBM? 
• Does the general status of the dogs contribute to the dog being more susceptible to 
B. canis infection? 
• Is B. canis endemic to South Africa? 
 
1.6 Benefits of the Study 
 The outcome of this research study will provide information on the B. canis disease status 
in South Africa, what the prevalence rate are in NMBM and the possible spread of the B. 
canis infection. Animal health care professionals will be more suspicious about B. canis 
when clinical symptoms are noticed and what tests could be used to confirm the infection. 
Furthermore, the dog owners and community can be made aware of the B. canis disease, 
the complications of the disease, and the health risks involved. 
  
1.7 Ethical Considerations 
The dogs that participated in this research study was not subjected to harm in any ways 
whatsoever and blood samples were collected according to the guidelines prescribed by the 
OIE. 
 
The protection of the privacy and anonymity of research participants in the townships and 
welfare organisations was ensured.  Throughout the study, respect for the dignity of 
research participants in the townships and welfare organisations was prioritised. All 
communication in relation to the B. canis research study was done with honesty and 
transparency with the participants. 
 
An adequate level of confidentiality of the research data collected, blood samples 
collected, and laboratory test conducted was obtained. Deception or exaggeration about the 
research results was avoided throughout the study.  
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Global reports on Brucella canis 
The first infected dogs were diagnosed in the United States of America (USA) in 1966 
(Carmichael, 1966) and since then, B. canis has spread globally, presenting itself in various 
different ways and has been diagnosed in many geographical areas.  
 
B. canis has been reported in the USA (particularly in the Southern States), Canada, Mexico, 
European countries, Tunisia, Nigeria, South Africa, Madagascar, the Philippines, Malaysia, 
India, Korea, Japan, Taiwan and China (CFSPH, 2012).  
 
Infection with B. canis is endemic in the Southern States of the USA, Central and South 
America, with a sero-prevalence rate of nearly 30% (Flores-Castro & Segura, 1975; 
Carmichael, 1990). Sporadic infections appear in Europe and Asia (Corrente et al., 2010), 
while Australia and New Zealand appear to be free of the organism (Wanke, 2004). Table 
2.1 provides an outline of countries with confirmed positive cases of B.canis and continents 
free of B. canis infection. 
 
Figure 2.1 Global distribution of B. canis across the eight different continents indicating 
the countries where B. canis was reported (Map source: NASA Earth Observatory) 
North America 
South America 
Africa 
Europe 
Asia 
Australia  
Oceania 
Antarctica  
 6 
 
Table 2.1 Countries with confirmed positive B. canis prevalence and continents free of B. 
canis infection (Source: C. Etsebeth, 2016) 
Continent Country  Continent Country 
Africa Madagascar  Europe Austria 
 Nigeria   Czech Republic 
 South Africa   Finland 
 Tunisia   France 
 Zimbabwe   Germany  
Asia China    Great Britain 
 Georgia   Greece 
 India   Hungary 
 Japan   Italy  
 Korea   Poland  
 Malaysia   Russia 
 Philippines   Serbia 
 Taiwan   Spain  
 Turkey   Sweden 
North America Canada     
 Mexico     
 United States   Antarctica  Free 
South America Argentina   Australia Free 
 Brazil   Oceania Free 
 Chile     
2.1.1  North America 
In the dog trade (“puppy mills”) in the USA, new untested animals and dogs from kennels 
led to the infection spreading and the need arose for regulatory procedures (Brower et al., 
2007). Outbreaks in the USA have been documented in Alabama (Lewis, 1972), Mexico 
(Flores-Castro & Carmichael, 1977), Texas (Hill et al., 1970), Colorado (Jones & Emerson, 
1984), Illinois and Wisconsin (Boebel et al., 1979; Rhoades & Mesfin, 1980), Michigan 
(Thiermann, 1980), Georgia (Brown et al., 1976; Wooley et al., 1977), Memphis, Tennessee 
(Lovejoy et al., 1976; Fredrickson & Barton, 1974) and Oklahoma (Petersen, 2008). In 
Alberta, Canada, an imported dog from Mexico was diagnosed with B. canis. Outbreaks in 
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Canada have also been reported in Ontario (Bosu & Prescott, 1980) and Quebec (Higgens 
et al., 1979). 
 
According to Petersen (2008), over the past 40 years, the number of B. canis cases has 
increased throughout the USA. In Oklahoma, the prevalence alone rose from 2% in 1994-
1995 to 13% in 2002-2003, corresponding with increasing costs associated with 
reproduction losses and euthanasia of infected dogs due to canine brucellosis (Welsh & 
Dirato, 2012).  
 
In the USA, the southern states have a higher prevalence of B. canis infection as compared 
to the rest of the country, with the prevalence in stray dogs being higher compared to owned 
animals (Greene & Carmichael, 2006). Compared to Mexico, Central and South America, 
the USA has a modest prevalence of canine brucellosis of 1-8%, compared to 20-30%, 
respectively (Greene & Carmichael, 2006).  
 
A serological sampling survey of 341 dogs from different regions of Quebec in Canada 
revealed a significant titer in six (1.8%) of the sera using the TAT. Some of the regions 
have shown a significantly higher number of up to 15% reactors than in other regions. 
Results from stray dogs also showed a higher prevalence compared to non-stray dogs 
(Chikweto et al., 2013; Fredrickson & Barton, 1974; Lovejoy et al., 1976). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Distribution of reported B. canis in countries, states and provinces across 
North America (Map source:  http://www.newportgeographic.com) 
 
 
Reported B. canis 
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2.1.2 South America 
The first known case of canine brucellosis was documented in the state of Minas Gerais, 
Brazil, in 1976 (Godoy et al, 1977). Since 1976, many other surveys were conducted 
throughout Brazil finding prevalence of between 0.84% and 58.3% (Miranda et al., 2005). 
A recent serological survey conducted in Araguaína, Tocantins (Dorneles et al., 2011), 
demonstrated a high prevalence of antibodies against B. canis in dogs. 
 
A study was done on 167 dogs from 19 different kennels in the São Paulo state, Brazil, 
(Boeri, 2008) using blood culture, genital culture, blood Polymerase Chain Reaction 
(PCR) and genital PCR. According to the results of these tests, the dogs were divided into 
three groups, namely; infected, non-infected and suspected dogs. Further diagnostic tests 
were done using the Rapid Slide Agglutination Test (RSAT), the 2-mercaptoethanol RSAT 
(2ME-RSAT) and the Agarose Gel Immunodiffusion (AGID) test. Results showed that 85 
dogs (68 females and 17 males) were classified as B. canis infected dogs, 42 dogs were 
classified as non-infected dogs and 40 were classified as suspected dogs (Keid et al., 
2009). 
 
Similar results across Brazil have been reported in Campinas, São Paulo, with a prevalence 
of 5.4% (Germano et al., 1987); in Belo Horizonte, Minas Gerais, 4.8% (Souza, 2001); in 
Monte Negro, 3.6% (Aguiar et al., 2005); in the metropolitan region of Salvador, de Bahia, 
5.8% (Cavalcanti et al., 2006); in the region of Ilheus-Itabuna, de Bahia, 3.4% (Bezerra et 
al., 2012); and in the Northern region of Paraná, 4% (Silva et al., 2012). All these studies 
were performed using the AGID test. 
 
Studies conducted with more significant prevalence values were reported at a kennel in 
Uruguaiana, Rio Grande do Sul, with a prevalence of 72.7% (Vargas et al., 1996); in 
Niterói, Rio de Janeiro , 25.7% (Maia et al., 1999); and in Araguaiana, Tocantins, 44.5% 
(Dorneles et al., 2011). Less significant values were also reported in the micro-region of 
Botucatu Mountains, São Paulo, a prevalence of 0.84% (Moraes et al., 2002) and in Sao 
Joao da Boa Vista, São Paulo, a prevalence of 0.80% for homeless dogs (Dos Reis et al., 
2008). 
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A study was conducted on 219 dogs in the lower-class neighbourhood and slums of 
Buenos Aires, Argentina, which revealed a prevalence of 7.3% for B. canis antibodies 
(Boeri, 2008). This study led to the isolation of three positive cases from these dogs by 
means of culturing. A more recent study in another area of Buenos Aires revealed a sero-
prevalence of 10.7% in dogs with two confirmed, isolated cases (Lopez, 2009). It is highly 
likely that the prevalence of B. canis infection in humans is much higher than currently 
suspected, as there is a gap in the testing of humans for this disease (Lucero et al., 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Distribution of reported B. canis in countries and states across South America 
(Map source:  http://www.newportgeographic.com) 
 
2.1.3 Europe 
The number of reported cases of B. canis from central Europe seems to be very low due to 
under-reporting of cases. This may be as a result of the status of B. canis with the World 
Organisation for Animal Health (OIE) and the European Union (EU) being not notifiable. 
However, published reports indicate an increase of B. canis and it is suggested that stray 
dogs serve as a reservoir in the Mediterranean area (Aras & Ucan, 2010). 
 
Von Kruedener detected B. canis for the first time in 1973 in West Germany, while Weber 
also documented infection (Weber & Schliesser, 1975). B. canis bacteria were isolated in a 
beagle colony with an estimated 200 breeding dogs. The birth rate of inseminated bitches 
dropped to only 29%, with an abortion rate of 50%, while 21% of bitches did not conceive 
 
Reported B. canis 
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(Von Kruedener, 1976). Shortly after Von Kruedener’s discovery, B. canis was isolated in 
Japan. 
 
B. canis infection has been described in various countries in Europe. In Finland, dogs 
diagnosed with B. canis were imported from Russia. The first outbreak of B. canis in 
Hungary appeared in a kennel and was only recently described by Gyuranecz et al. (2011). 
In Italy and Germany, reported cases of B. canis infection were found in male dogs (Nockler 
et al., 2003; Corrente et al., 2010). In Austria, three poodle bitches in a kennel were 
described infected with B. canis (Schäfer-Somi & Hofer, 2011), as well as a case involving 
a crossbred bitch from Greece and a purebred male dog that tested positive for B. canis 
infection (Schäfer-Somi & Hofer, 2011). Both B. abortus and B. canis antibodies were 
detected in a male dog in Poland (Kopczewski et al., 1995). Serological evidence was 
provided that B. canis infection is present in Great Britain (Taylor, 1980), Italy (Ebani et al., 
2003). A dog imported from Spain was reported in Great Britain to be infected with B. canis 
(Mateu-de-Antonio et al., 1994). B. canis infection has also been reported in the former 
Czechoslovakia in laboratory dogs and in France in kennel dogs. Control strategies were 
developed for B. canis infection in Georgia in 2003 after infected dogs were recorded 
(Hollet, 2006). 
 
In May 2008 in Italy, a six-year-old intact male dog with chronic prostatitis, discospondylitis 
and locomotor problems was admitted to the Hospital of the Faculty of Veterinary Medicine 
of the University of Bari. Tissue and blood samples from the dog were subjected to clinical 
and laboratory examinations using microbiological analysis, PCR assays and serological 
investigations. B. canis was detected by PCR (specific for B. canis) in tissue samples and 
biological fluids. The RSAT detected antibodies against B. canis and the CFT detected low 
antibody titres of 1:8 (Corrente et al., 2010). 
 
B. canis was diagnosed for the first time in Sweden in 2011 in a three-year-old terrier that 
was imported from Poland. The first male dog she was mated with was from Serbia and 
when she did not conceive, she was mated with a second dog in Poland (Kopczewski et al., 
1995). After the first reproductive failure, all three dogs were tested serologically for B. 
canis, with negative results. Five months later after a caesarean section, the placenta was 
sent for bacteriological analysis for B. canis. The culture result from the placenta was 
positive for B. canis (Holst et al., 2012). 
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Figure 2.4 Distribution of reported B. canis in countries across Europe (Map source:  
http://www.newportgeographic.com) 
 
2.1.4 Asia 
In Asia, positive reports were obtained from Japan (Azuma & Isayama, 1973), India, the 
Philippines, Korea, China, Malaysia and Taiwan. According to Akhtardanesh et al. (2011), 
B. canis is endemic in the south-eastern part of Iran and could therefore be considered a new 
emerging disease, with dogs being at higher risk from brucellosis-infected farms.  
 
A study done in dogs of the Fars Province of Iran showed the prevalence of B. canis 
antibodies to be 10.62% (Behzadi & Mogheiseh, 2011). The results of this study showed 
that the infected dogs were all exotic breeds, while the non-infected dogs were mixed and 
spray (native) breeds. In the endemic area of this study, stray dogs are indicated as the source 
of infection due to the fact that control and preventative measures have been taken with 
companion dogs (Mohammad & Asghar, 2011). 
 
In the southwest of Iran, at the Veterinary Hospital of Shahid Charman University of Ahvaz, 
a study was done to determine the sero-prevalence of B. canis infection in companion dogs. 
Blood samples were obtained from 102 companion dogs referred to the Veterinary Hospital. 
A commercial Rapid B. canis AB Test Kit (Cat No: RB21-03) was used to examine the sera. 
Results showed that five (4.90%) out of the 102 were positive for B. canis infection 
(Mosallanejad et al., 2008). This study was the first report in Iran on the prevalence of B. 
canis in dogs using immunochromatography.  
 
Reported B. canis 
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During 2003, a study was done on 362 serum samples from eight kennels in Turkey and the 
results indicated a prevalence of approximately 28%. Only two of the eight kennels 
examined tested negative for the disease (Mehmet et al., 2003). The negative result from 
these two kennels can be related to the low number of dogs residing in these kennels during 
the time of sampling.  
 
In 2010 in Turkey, Aras and Uçan first detected the B. canis causative agent in dog samples 
taken at a dog shelter. The results indicated that four (8%) out of the 48 dogs that had died 
of an unknown reason were infected with B. canis (Aras & Uçan, 2010). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 Distribution of reported B. canis in countries and provinces across Asia (Map 
source:  http://www.newportgeographic.com) 
 
2.1.5 Africa 
A study done by Momoh et al., (2015) in Jos, Nigeria, showed a prevalence rate of 32.3% 
using the Rose Bengal Plate Test (RBPT). Serum samples were collected from 350 dogs, 
resulting in 113 positive samples. From the positive samples, 83 (73.5%) of the dogs showed 
clinical signs of abortion and/or stillbirths, while 30 (26.5%) did not have any clinical signs 
(Momoh et al., 2015).  
 
Cadmus et al., (2011) did a sero-prevalence study on 366 dogs in Lagos and Ibadan, Nigeria, 
which resulted in 0.27% dogs testing positive by means of the Rose Bengal Test (RBT) and 
the RSAT. The researchers indicated that further studies in Nigeria would have to be done 
to provide more insight into the prevalence of B. canis infection in dogs. 
 
Reported B. canis 
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In urban Harare and rural communities in Zimbabwe, a cross-sectional study was done to 
detect antibodies against B. canis in dogs. An enzyme-linked immunosorbent assay (ELIZA) 
test was used to test for antibodies of B. canis. Results showed that 17.6% of the 324 samples 
tested were positive for B. canis antibodies. Dogs from the rural communities showed a sero-
prevalence of 12.7%, while the dogs from urban Harare showed a higher sero-prevalence of 
20.7%. Positive dogs from urban Harare all had titres below 1:400, while two of the positive 
dogs from the rural communities had titres of 1:800 and 1:600. The tests confirmed the 
presence of B. canis in the study area and this could be considered as a risk (Chinyoka et al., 
2013). 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 Distribution of reported B. canis in countries and provinces across Africa 
(Map source:  http://www.newportgeographic.com) 
 
Some countries have eliminated or reduced the disease through eradication programmes, 
while the situation is still endemic in countries like Nigeria, with huge economic burdens to 
contain or maintain a free status (Cadmus et al., 2011). However, in Africa, there is an 
inadequate amount of information on canine brucellosis in Nigeria (Adesiyun et al., 1986; 
Cadmus et al., 2011), South Africa (Gouws et al., 2005) and Zimbabwe (Gomo, 2013; 
Chinyoka et al., 2013). 
 
2.2 Brucella canis in South Africa 
In South Africa, the dogs that confirmed positive for the B. canis antigen had no known 
contact with any imported animals, therefore, the possibility that B. canis is endemic in 
South Africa cannot be excluded where stray dogs may serve as a reservoir (Gouws et al., 
2005). 
 
Reported B. canis 
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In November 2005, Gouws et al., (2005) reported the existence of B. canis in South Africa. 
The first confirmed report of the B. canis organism in South Africa came about after B. canis 
was isolated from two unrelated crossbred dogs with discospondylitis during April and 
August 2005. The first case originated from the Society for the Prevention of Cruelty of 
Animals (SPCA) in Cape Town and the second case was a stray from Knysna. The female 
dog exhibited signs of cervical pain and was diagnosed with discospondylitis by a specialist 
veterinary surgeon (Gouws et al., 2005).  
 
Blood was collected for bacterial culture and the Brucella species was isolated from both 
dogs (Gouws et al., 2005). These cultures were identified as B. canis by Onderstepoort 
Veterinary Institute (OVI) and Veterinary Laboratories Agency (VLA). Both isolates were 
confirmed as Brucella species by using an IS711 PCR test, also known as IS6501 (Gouws 
et al., 2005). 
 
At the Western Cape Provincial Veterinary Laboratory, a CFT was performed on the serum 
from the dog originating from Cape Town. Brucella ovis was the antigen used, which 
revealed a high positive CFT titre of 784 IU. OVI also performed the Rapid Slide 
Agglutination Test (RSAT) and the 2-Mercaptoethanol - RSAT (2ME-RSAT) on the same 
dog, and both tests revealed a positive result (Gouws et al., 2005).  
 
These two positive cases that were identified five months apart were indicative of a higher 
prevalence of B. canis than reported (Gouws et al., 2005). The report concluded that B. canis 
might be endemic in South Africa with possible distribution limited to stray dog populations.  
 
According to the Western Cape agricultural sector, B. canis was isolated from a female dog 
in Hermanus in September 2012 (Van Helden, 2012). Four cases were isolated from dogs in 
the Eastern Cape Province, one in Bedford, Somerset East in 2010 and three more in the PE 
area, one in 2013 and two in 2014 (Dr JB Strydom, State Veterinarian Port Elizabeth)*. 
 
2.2.1 Brucella canis in the Nelson Mandela Bay Metropolitan (Port Elizabeth)  
In September 2013 in Steytler Township, a one-year-old dog diagnosed with 
discospondylitis tested positive for B. canis. The dog was purchased on a street corner in 
                                                          
 Personal Communication 
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December 2012 and this date was stated as the estimated date of first infection. In January 
2014 in Lorraine, a two-year-old dog suffering from stiffness and musculoskeletal 
discomfort was radiographed showing discospondylitis, and serologically tested positive for 
B. canis. The estimated date of first infection was January 2012. In February 2014 in 
Sherwood, blood and fluid samples were taken from a six-year-old dog that presented with 
inflammation and swollen joints, and both samples tested positive for B. canis. The 
estimated date of first infection was October 2008 (Dr JB Strydom, State Veterinarian Port 
Elizabeth). 
 
After the initial laboratory test in PE, all the cultures and blood samples were sent to OVI 
for confirmation. The bacteria culture samples were confirmed by OVI on growth and 
primary biochemical characteristics as Brucella species and identified on phenotypic test as 
B. canis. The results were also confirmed by ARC-OVI by means of a PCR test. 
 
 
 
 
 
 
 
 
 
 
Figure 2.7 Previous reported cases of B. canis in Port Elizabeth (Source: C. Etsebeth, 
2016)  
                                                          
 Personal Communication 
SHERWOOD 
LORRAINE 
STEYTLER 
PORT ELIZABETH 
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CHAPTER 3 
CANINE BRUCELLOSIS 
 
3.1 History of Brucella canis 
B. canis was first identified in the United States in 1966. Although an epidemic of 
reproductive failure and contagious abortion in beagles was first noted in 1964, the first 
detailed reports of the causative agent, B. canis, were made by Dr LE Carmichael at Cornell 
University in 1966. He described the organism: “A gram-negative coccobacillary bacterium 
was isolated in pure culture from foetal and placental tissues of several pups. Cultured, 
biochemical and serological characteristic has indicated that the organism is a member of 
the Brucella family” (Carmichael, 1966). During 1966 – 1967, B. canis was also isolated 
from canine tissue and vaginal discharges (Carmichael & Kenny, 1968). 
 
Following the identification of B. canis in dogs in 1966 as a cause of reproductive failures 
and abortions, several sero-epidemiological studies were conducted in the 1970s to 
determine whether this Brucella pathogen is a zoonotic threat to the human population.  
 
3.2 Etiology 
The genus Brucella is composed of a gram-negative bacterium that generates characteristics 
of intracellular bacterial infections in both animals and humans. Canine brucellosis is a 
chronic infectious zoonotic disease whose main etiological agent, Brucella canis bacterium, 
is a rough, small, gram-negative coccobacillus, non-motile, intracellular proteobacterium in 
the Brucellacea family (Greene & Carmichael, 2006). B. canis forms rugose colonies 
differentiating it from the classical and novel species in the genus Brucella, excluding B. 
ovis (Carmichael & Bruner, 1968; Carmichael & Greene, 1990; Berthelot & Garin-Gastuji, 
1993). B. canis can grow on common artificial culture media, including tryptose agar, and 
does not require CO₂ for culturing.  
 
B. canis can also have smooth Brucella similar to B. melitensis, B. abortus and B. suis as the 
etiological agent (Carmichael & Greene, 1993). The smooth Brucella are usually caused by 
contact with infected livestock such as cattle, sheep, goats and pigs that are infected or by 
eating infected raw meat (particularly afterbirth products). Dogs infected with smooth 
Brucella are likely to show symptoms similar to those animals infected with B. canis. 
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3.3 Brucella canis overview  
Under natural conditions, domestic dogs and wild Canidae are the only animal species that 
serve as reservoirs for the B. canis bacterium. According to Carmichael (1990), canine 
brucellosis usually affects domestic dogs, wild carnivores, and rarely other domestic 
animals, and occurs mainly in Central and South America.  
 
B. canis, a zoonotic organism that causes canine brucellosis in dogs, is a significant cause 
of reproductive failure in dogs worldwide (Wanke, 2004); particularly in kennels. B. canis 
may significantly reduce the number of pups weaned in breeding kennels. According to the 
CSFPH (CFSPH, Iowa State University (ISU), 2007), canine brucellosis can end the 
reproductive life of a breeding animal.  
 
The CFSPH further states that the associated environment where infected dogs roam may 
be contaminated with B. canis. Information relating to Brucella spp. demonstrates that the 
bacteria can remain viable in a contaminated environment for long periods depending on 
favourable temperature and other conditions. Cool moist conditions favour survival and the 
most likely route of transmission is through contaminated faecal matter, urine and other 
bodily secretions (CFSPH, ISU, 2007). 
 
Canine brucellosis is systemic, contagious and insidious, without pathognomonic 
symptoms. The clinical signs are not appropriate to establish a diagnosis, but the infection 
can be characterized by prolonged bacteraemia, abortion in the third term of gestation and 
persistent vaginal discharge (Carmichael & Joubert, 1988). Asymptomatic male and female 
dogs harbour the B. canis organisms for prolonged periods. The average duration of time 
from initial exposure to a bacteraemia is approximately three weeks, after which the 
organisms localize in targeted genital tissues. Distribution of the bacteraemia can last from 
months to years by either a continuous or recurrent release of the bacteria. The prostate and 
epididymites of the male dog serve as effective genital sites for bacterial emissions. 
However, it is possible for the bitch to show no clinical signs of Brucella infection before 
having sudden abortions or an onset of infertility (Hollett, 2006). 
Purebred dogs, in general, have a higher prevalence than crossbreed dogs. However, any 
sexually mature and reproductively active dog is susceptible (Spink & Morrisset, 1970; 
Blankenship & Sanford, 1975). Uncontrolled, stray and feral dogs remain predominant 
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reservoirs in the environment (Carmichael, 1979; Flores-Castro & Segura, 1975; Flores-
Castro & Carmichael, 1977; Ramacciotti, 1978; Tsai et al., 1983; Brown et al., 1976a). 
 
The true prevalence rates among kennels and breeding dogs are unknown worldwide, and 
thus much of the B. canis epidemiology remains unclear. 
 
3.4 Clinical signs 
Females 
Clinical signs of B. canis vary from asymptomatic infertility to overt abortion in dogs. In 
pregnant bitches, the infection localises in the reproductive tract where it causes placentitis 
with subsequent abortions and stillbirths (Lopes et al., 2010). However, early embryonic 
deaths (EED) and foetal resorption can occur 10-20 days after mating and may be mistaken 
for apparent failure to conceive (Lopes et al., 2010) or, as stated by Hollett (2006), observed 
conception failure. After 45-55 days of gestation, approximately 75% of infected bitches 
may abort, followed by a prolonged period of vaginal discharge (Hollett, 2006).  
 
Males 
The Brucella organism is harboured in the prostate gland, testicles and epididymitis of the 
infected male. The organism can be harboured for several months after the bacteraemia has 
ceased. Carmichael and Shin (1996) reported the bacteraemia might disseminate the 
infection during subsequent breeding. In infected male dogs, various symptoms have been 
observed, which included infertility, moist scrotal dermatitis, epididymitis of testicles, 
painful scrotal enlargement or testicular atrophy, orchitis and prostatitis (Carmichael & 
Kenney, 1968; Hollett, 2006). The semen evaluated from male dogs chronically infected 
with the Brucella organism can show a reduced number of immature sperm, aspermia and 
head-to-head agglutination of sperm. The intact stud dog will have a decreased volume of 
ejaculate, loss of libido and reluctance to breed. In the first three months following infection, 
the semen samples evaluated showed a high percentage of morphologically abnormal sperm 
and inflammatory cells. The seminal fluids and, occasionally, urine disseminate the bacteria 
(Shin & Carmichael, 1999). 
In either gender, nonspecific signs include lethargy, premature aging and generalized lymph 
node enlargement (lymphadenitis), loss of libido and unwillingness to breed (Hollett, 2006). 
Despite being infected, in most cases, many dogs remain asymptomatic and appear to be 
healthy (Behzadi & Mogheiseh, 2011), but severe lymphadenitis involving the 
 19 
 
retropharyngeal and inguinal lymph nodes may be found (Wanke, 2004). Signs of 
discospondylitis, meningoencephalitis or uveitis can develop in either gender as a result of 
B. canis infection. These signs may be noticed by performing a physical examination or 
during routine survey films. 
 
3.5 Transmission of Brucella canis 
A predominant route is venereal transmission where the likelihood for spread remains high 
due to large numbers of organisms shed in reproductive secretions. In all canids, 
transmission occurs by means of breeding or ingestion of contaminated reproduction 
materials and/or secretions from infected bitches. The possibility of long-term infection and 
shedding of B. canis infected sperm and vaginal secretion after abortions has been proven 
(George et al., 1979). The organisms may be shed for several weeks or, intermittently, for 
months following an abortion (Nicoletti, 1989).  B. canis infection in dogs may result in 
prolonged bacteraemia, which makes blood culturing a valuable method in the diagnostics 
for B. canis (Carmichael & Kenney, 1970).  
 
Weber and Christoph (1982) state that low concentrations of the Brucella bacteria have been 
isolated from saliva, nasal and ocular secretions, and faeces. Even though it is of low 
importance, it is still a source of infection.  
 
Brucella bacteria can be found in concentrations up to 10¹⁰ per ml in vaginal secretions 
during oestrus and parturition, abortion and post-partum in the foetus, placenta and lochia 
(Carmichael & Greene, 1990). Pups can be infected in utero, intrapartum or during nursing. 
The infective dose in dogs ranges from 10⁴ for the conjunctival exposure route to 10⁶ for 
the oral route (Greene & Carmichael, 2006). 
  
The role of milk in the dissemination of B. canis is controversial, although the bacterial 
concentration in milk is relatively high or the role of milk in the dissemination of B. canis is 
considered unimportant due to the “in utero” infection of pups. The dangers of infected milk 
are considered in the environmental contamination by other authors (Carmichael & Greene, 
1990). 
 
Young males also may shed organisms in the urine, but bacterial numbers are relatively low, 
except when urine is contaminated with seminal or prostatic fluids. Urine from sexually 
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mature male dogs is more dangerous as a source of infection, because of the higher 
concentration of bacteria. Urine may be infectious in puppies as early as 4 to 8 weeks of age 
and the bacterial count can be up to 10³ – 106 bacteria cells/ml of urine with the concentration 
of infection at its highest between four to six months after initial infection (Serikawa et al., 
1978). Urine becomes the contaminated vehicle because of the close anatomical connection 
of the bladder to the secretory prostate and epididymis (Hollet, 2006). Males harbour the 
organism in their genital tracts, from which it is shed intermittently, and it can be transmitted 
to the female by coitus. 
 
Infection can occur through all mucosae and by many routes of inoculation. Bacteraemia 
follows and although it may be intermittent, it is prolonged and may persist for two years 
after the initial infection (Carmichael & Kenney, 1968). 
 
In a kennel environment, the aborting bitch becomes a high risk for spreading the B. canis 
infection. Transmission of B. canis occurs principally at the time of abortion, when bacteria 
are shed in the continuous vaginal discharge. Transmission by this route may continue for 4 
to 6 weeks after an abortion (Carmichael, 1976; Hollet, 2006). Large numbers of B. canis 
organism is present in the aborted placental tissue and fluid. These organisms consist of two 
million colony units forming in an infective dose or 1010 organisms/ml in discharge, which 
constitutes 500 oral infective doses/ml (Serikawa et al., 1978; Hollet, 2006).  
 
3.6 Diagnosis 
Definitive diagnosis can be made with obtaining bacteria from tissue, vaginal discharge, 
blood, semen, vertebra or the eye. Results from positive serologic agglutination testing, other 
serologic titres and haemoculture results aid as supportive evidence. Difficulty with 
diagnosis occurs with the fluctuant levels and length of the bacteraemia in the dog (Taul, et 
al., 1967). A negative blood culture does not eliminate B. canis as the etiology agent. 
 
The diagnosis of canine brucellosis requires laboratory confirmation. According to 
Carmichael and Shin (1996), blood cultures are strongly recommended before declaring an 
animal infected. Serological tests, which are currently available to most veterinarians in the 
USA, are imprecise since surface antigens of rough Brucella, such as B. canis, cross-react 
strongly with antibodies against several other non-pathogenic bacterial species (Carmichael 
& Shin, 1996).  
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The presumptive diagnosis of canine brucellosis is based on clinical signs and requires 
further confirmation through culture and isolation of the causative bacteria (Bae & Lee, 
2009). While culture and isolation are regarded as the standard test for laboratory diagnosis 
of brucellosis, its sensitivity is low because the Brucellae are fastidious micro-organisms 
that can easily be overgrown by contaminating bacteria (Bae & Lee, 2009).  
 
Serological examinations are often used to detect evidence of exposure to B. canis since they 
are relatively easy to perform and may provide a practical advantage of estimating 
prevalence in populations (Bae & Lee, 2009).  
 
3.6.1 Tube Agglutination Test (TAT) 
A serological test examines the agglutinating reaction to the cytoplasmic protein antigen or 
cell wall. During the first three to four weeks of infection, these results may be negative 
even though the dog is already experiencing bacteraemia two weeks after infection (Greene 
& Carmichael, 2006). The TAT detects antibodies against B. canis in dogs that test positive 
with the RSAT or the ME-RSAT. The TAT is sensitive, but not specific and thus allows 
false positive results to occur. A confirmatory titer from a TAT will give a positive result –
two to four weeks following exposure to the bacteria or bacteraemia. 
 
When performing a TAT, a specific amount of test serum is added to the diluted B. canis 
antigen. The B. canis antigen solution is a suspension of heat-killed and washed B. canis 
bacteria. Results of the TAT are semi-quantitative with a 1:200 titre presumptive evidence 
of an active infection (Fredrickson & Barton, 1974; Rhoades & Mesfin, 1980; Flores-Castro 
et al., 1977; Henderson et al., 1974). Titres that are measurable below 1:200 should be tested 
and retested two weeks later.  
 
According to Pollock (1979), the TAT, RSAT and ME-RSAT do indeed detect the 
agglutinating antibodies from the dog, but those same antibodies do not protect the dog from 
the bacterial infection. The infected dog remains bacteraemic for an uncertain number of 
years despite a positive agglutinin titre (Serikawa et al., 1978; Center for Disease Control, 
1977).  
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The bacteraemic dog can spontaneously recover naturally one to five years after the initial 
bacterial infection (Greene & Carmichael, 2006). Due to recovery, the dog becomes 
abacteraemic and the now low agglutination titres of 1:25 to 1:50 suggest a clearance of the 
bacteria (Flores-Castro & Carmichael, 1977). A cellular immunity starts to develop from 
this natural recovery preventing reinfection. 
 
3.7 Brucella canis in humans 
Although humans are susceptible to B. canis, infections are uncommon and usually mild. 
According to Young (1983), B. canis is considered a rare cause of human brucellosis and 
the most common type of contagion is through contact with infected dogs, their secretions 
or through direct laboratory exposure. Individuals who handle breeding dogs in kennels and 
are exposed to reproductive tissues and fluids are at higher risk of exposure. Infections 
caused by exposure to bacterial cultures in the laboratory have also been reported. According 
to Lucero et al. (2002), close contact between man and infected dogs increases the risk of 
transmission, although the impact on public health is underestimated due to the lack of 
reporting and inadequate diagnostic services. It is also highly likely that the prevalence of 
B. canis infection in humans is much higher than currently suspected, since there is a gap in 
the testing of humans for this disease (Lucero et al., 2010). 
 
The most common symptoms reported in young children infected with B. canis are fever, 
diarrhoea, vomiting and headache, with fatigue, myalgia and nausea (Nomura et al., 2010). 
Symptoms in adults are usually vague and include prolonged fever, lymphadenopathy as 
well as endocarditis. Unlike the dog, infected humans usually respond rapidly to antibiotics 
(Carmichael & Shin, 1996). Brucellosis has a greater impact on immunosuppressed 
individuals, children and pregnant women. 
 
3.7.1 Diagnosis 
In order to detect antibodies against Brucella, routine clinical diagnostics for human 
brucellosis were developed. These diagnostic tests were to detect antibodies against smooth 
Brucella antigens (B. abortus, B. melitensis and B. suis) and not to detect antibodies against 
rough Brucella antigens (B. canis and B. ovis) (Moreno et al., 1984). It is of clinical 
importance that human B. canis infections are likely to be misdiagnosed and hence under-
reported (Polt & Schaefer, 1982).  
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In the absence of human serological tests, the lack of clinical suspicion, ill-defined clinical 
presentations, low levels of periodic bacteraemia and the selective nature of the organism in 
culture further limit the diagnosis of B. canis in humans (Scheftel, 2007). 
 
B. canis is underdiagnosed not only due to a general lack of serological testing facilities, but 
also due to misconceptions concerning its prevalence (Scheftel, 2007).  
 
3.7.2 Epidemiological studies 
The epidemiology of B. canis infection in humans is poorly understood. Human brucellosis 
is a nationally notifiable disease to the Centers for Disease Control and Prevention (CDC) 
in the USA. However, the CDC does not receive data on the etiological species when 
brucellosis cases are reported. 
 
After B. canis was identified in dogs by Leland Carmichael in 1966, several sero-
epidemiological studies were conducted to determine whether B. canis was a zoonotic threat 
to humans. Occasional case reports of human clinical infections with B. canis is presented 
in literature, most involving direct exposure to a confirmed B. canis positive dog (Swenson 
et al., 1972; Tosi & Nelson, 1982; Young, 1983; Lum et al., 1985; Rousseau, 1985; 
Schoenemann et al., 1986). The first four reported cases of B. canis in humans were 
laboratory exposures, and the fifth case was an animal caretaker with asymptomatic 
serological evidence of exposure. However, the sixth case in 1970 was the first naturally 
acquired human infection that occurred (Swenson et al., 1972). 
 
In 1973, a sero-prevalence study of 1 208 healthy US military recruits identified five 
(0.4%) with serologic evidence of current or previous B. canis antibodies (Lewis & 
Anderson, 1973). In 1974 in Florida (US), a study examined 167 animal shelter workers 
and 43 veterinarians from 21 establishments in 16 counties (Hoff & Nichols, 1974; Hoff & 
Schneider, 1975). Results revealed that only one of 167 shelter workers (0.59%) tested 
positive for B. canis antibodies with agglutinin titres of ≥1: 200. No veterinarians tested 
positive. 
 
Monroe et al. conducted a study in 1975 examining the sero-prevalence of B. canis among 
a US cohort divided into four categories: newborn infants with no exposure (N=193), 
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hospitalized/non-hospitalized patients, hospital employees and blood donors with average 
dog exposure (N=2,026), practicing veterinarians with high exposure (N=73), and patients 
with fever of undetermined origin (N=113). Employing the modified microtiter plate 
agglutination technique (Damp et al., 1973), the sero-prevalence rate for the groups was 
5.7%, 67.8%, 72.6% and 80.5%, respectively. With a reported 81% of febrile patients testing 
seropositive, results suggested that B. canis was eliciting clinical illness in humans. The 
overall sero-prevalence results showed that 81% of febrile patients tested positive for B. 
canis. 
 
A study in 1975 tested convenience samples from 513 Florida residents and found two 
(0.39%) persons seropositive for B. canis infection. This study used the TAT employing 
rough lipopolysaccharide antigen. A serological study done on 203 hospital patients in 
Mexico during 1976 found a sero-prevalence of 13.3% (27 positives) (Flores-Castro & 
Segura, 1975).  
 
In 1977, a study examined 1 915 human sera samples, where three (0.2%) subjects were 
confirmed positive (Webber & Brunner, 1977). In 1979 in rural Argentina, a study using the 
cross-reacting B. ovis antigen found that out of 1 952 people, 23 (1%) tested positive for B. 
canis antibodies (Varela-Diaz & Meyer, 1979). In 1982 in the USA, a study detected B. 
canis antibodies in four (0.3%) of the 1 147 human sera tested; all four were patients with 
undiagnosed febrile illness (Polt et al., 1982) 
 
In Japan, the first case of Brucellosis was reported in 1933 and Brucella became a notifiable 
disease in April 1999. Between 1999 and 2012, 19 cases of Brucellosis in humans were 
reported. Among those cases, five were from B. melitensis, two from B. abortus and 12 from 
B. canis. Diagnosis was made on positive antibody detection (Infectious Agents Surveillance 
Report (IASR), 2012). 
 
 A laboratory worker with exposure to live M-cells for B. canis antigen production 
developed clinical illness (Wallach et al., 2004). Two B. canis cases were reported causing 
clinical infections in Human Immunodeficiency Virus (HIV) patients following exposure to 
positive dogs (Lucero et al., 2010b; Lawaczeck et al., 2011). The first documented outbreak 
in humans was reported in a family of six, which consisted of three adults and three children 
(Lucero et al., 2010a). The family developed B. canis infections following exposure to a 
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sick dog and her puppies. The index case was initially misdiagnosed, but the organism was 
detected by a subsequent positive culture. 
 
Momoh et al. (2015) conducted a study in Jos, Nigeria, to determine the risk factors and 
level of awareness among dog owners with regard to canine brucellosis. The eating of dog 
meat is acceptable in the culture of the residents in Jos, Nigeria, resulting in a large 
population of dogs. Serum samples were collected from 350 dogs and interviews held with 
the dog owners. The serum collected from the dogs showed a prevalence of 32.3% using the 
RBPT. Results from the interview showed that 76.9% of the dog owners lacked knowledge 
of the disease, and the results from the questionnaire revealed that 75% of the dog owners 
consumed suya (roasted) dog meat, 21% boiled dog meat and 4% fried dog meat (Momoh 
et al., 2015). This indicated that there is a relevant risk of being infected with B. canis when 
consuming dog meat of B. canis infected dogs. 
 
It seems likely that B. canis infections in humans are significantly underdiagnosed and 
under-reported primarily due to the nonspecific presentation of the disease and the lack of 
readily available laboratory testing. 
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CHAPTER 4 
MATERIALS AND METHODS 
 
4.1 Research design 
The prevalence of B. canis is unknown in South Africa since being identified in 2005. This 
research study was designed investigate the prevalence of B. canis in dogs in the NMBM 
(PE) were previous cases have been identified. A questionnaire was used to obtain the 
general status of individual dogs and a combined dog population of NMBM. Blood samples 
were taken from each dog to test for B. canis antibodies, the test used was the TAT, 2ME-
TAT and CFT. The TAT was used as a screening test and the CFT as a confirmations test. 
Results from the laboratory test were combined with the variables obtained from the 
questionnaire, to determine if the variables have an influence on the dogs’ susceptibility for 
the disease. For statistical analysis, the two proportion Z-test was used to compare the 
variables as well as the laboratory test results. 
 
4.1 Study area 
This study was conducted in PE in the NMBM (Eastern Cape), in collaboration with the 
state veterinarian, townships and welfare organisations. All seven major townships of Port 
Elizabeth were chosen for the research survey. 
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Figure 4.1 The Nelson Mandela Bay Metropolitan, Port Elizabeth (Source: C. Etsebeth, 
2016) 
 
4.1.1 Port Elizabeth – Nelson Mandela Bay Metropolitan 
PE is part of the NMBM area that includes Despatch, Uitenhage and Ibhayi and is located 
in the Eastern Cape of South Africa (Figure 4.1). The NMBM covers an area of 1 958.91 
km² and, with its current population of 1.3 million, it is the fourth largest city in South Africa, 
it is also South Africa’s second oldest city.  
 
Situated in Algoa Bay is PE, one of the largest cities and an important harbour in South 
Africa. Other major towns include Bisho, the capital; Uitenhage, which has important motor 
vehicle manufacturing and related industries; King William’s Town, rich in early settler and 
military history; Grahamstown, also known as the City of Saints because of its more than 40 
churches; as well as Mthatha, Graaff-Reinet, Cradock, Stutterheim, Summerstrand Beach, 
Aliwal North and Port St Johns, the largest town on the Wild Coast. 
 
As a result of human population growth and heightened awareness of animal welfare and 
disease issues, increased attention is being given to the problem of stray and uncontrolled 
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dogs. According to Odendaal (1994), more than 30 dogs/100 people can be found in the 
informal communities of South Africa. 
 
Human:dog ratios obtained from detailed studies in a range of rural and urban settings 
worldwide are used as a preliminary guideline of the number of dogs owned for planning 
purposes and vaccine procurement (caninerabiesblueprint.com). A human:dog ratio of 
21:20 in urban areas and 11:10 in rural areas can be used as a preliminary guideline for South 
Africa (Knobel et al., 2005). 
 
Table 4.1.2 Estimated dog population in Nelson Mandela Bay Metropolitan  
Name of Town 
Census 
2011-10-09 
Estimated Dog 
Population 
Estimated 
Dogs Sampled 
Bethelsdorp 182 012 8 585 60 
Blue Horizon Bay 419 20 1 
Clarendon Marine 2 434 115 1 
Colchester 2 073 98 1 
Despatch 39 619 1 869 13 
Ibhayi 237 799 11 217 79 
KwaNobuhle 107 474 5 070 35 
Motherwell 140 351 6 620 45 
Nelson Mandela Bay NU 23 542 1 110 8 
Port Elizabeth 312 392 14 735 103 
Uitenhage 103 639 4 889 34 
Woodridge 362 17 1 
Nelson Mandela Bay Metropolitan 
Municipality 
1,152,115 54 345 381 
 
The total sample size was determined by using the Sample Size Calculator (source: 
www.surveysystem.com/sscalc.htm#one). A confidence level of 95% and a confidence 
interval of 5% are used for the calculation reflecting the dog population. 
 
4.1.2 Townships and informal settlements 
The city of PE consists of seven major townships and many other informal settlements. 
These townships are KwaZakhele, New Brighton, KwaDwesi, KwaMagxaki, Motherwell, 
Walmer and Zwide. According to the Eastern Cape Socio-Economic Consultative Council 
 29 
 
(ECSECC) the proportions of dwellings classified as informal settlements during 2010 were 
a ratio of 17.26% in the NMBM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 The major townships of Port Elizabeth (Source: C. Etsebeth, 2016) 
 
4.1.3 Kennels and welfare organisations 
Indicated in Figure 4.3 are the welfare organisations that willingly took part in this 
surveillance. These organisations are the Animal Anti-Cruelty League (AACL), the Animal 
Welfare Society Port Elizabeth (AWS (PE)), and the Save-a-Pet Rehabilitation Centre. 
 
 
 
 
 
 
 
 
 
Motherwell 
KwaZahkele 
Zwide 
KwaMagxaki 
New Brighton 
Walmer 
KwaDwesi 
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Figure 4.3 Kennels and Welfare Organisations within Port Elizabeth (Source: C. 
Etsebeth, 2016) 
 
The AACL is South Africa’s second largest independent Animal Welfare Organization, 
relying entirely on the public for financial support with a clinic located in Cleary Park, PE. 
The AACL treats an average of 1 300 animals per month and provides daily and weekly 
assistance at squatter camps and underprivileged, indigent communities in the northern areas 
of the NMBM. The AACL is involved in all aspects of animal welfare, including prosecuting 
animal cruelty cases (http://www.aacl.co.za/). 
 
The AWS (PE), located in Walmer, is the only animal shelter in PE offering a safe place for 
unwanted, abandoned and lost animals. Running catteries and kennels for stray and 
surrendered pets, the AWS (PE) also have facilities available for other animals, birds and 
livestock. The AWS (PE) accepts all animals brought to them and deals with reported cases 
of neglect and cruelty of animals (http://www.animalwelfarepe.co.za/).  
 
The Save-a-Pet Rehabilitation Centre is an organisation functioning with a pro-life policy 
that rescues, rehabilitates and re-homes animals that have been abandoned and abused. 
AACL 
Save-A-Pet 
AWS(PE) 
PORT ELIZABETH 
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Located near Greenbushes, PE, Save-a-Pet is actively involved in the surrounding informal 
areas providing aid in general animal care, feeding and sterilising of dogs and cats 
(http://www.saveapet.co.za/). 
 
4.2 Questionnaire  
A questionnaire-based survey of the dogs was conducted during sample collection. Details 
and additional information needed were recorded on the data sheet developed according to 
specific needs and the objectives of this study. A sample number was allocated to each 
individual dog as well as the date collected, age, gender, spayed or neutered, number of dogs 
per household, body condition score (BCS), and vaccination history. Other relevant data on 
the questionnaire included the area of origin, possible clinical signs and general welfare of 
the dogs in the survey area. All the data collected† per questionnaire created a profile of each 
individual dog and all the data combined provided the general status of the dogs in the study 
area. 
 
The BCS was assessed by using a numeric scale from 1 – 5. Assessing BCS is a method to 
both visually evaluate the muscling and body fat and by palpating the adipose tissue mass. 
Visual evaluation is executed from the side and from the top of the dog, while palpation was 
executed by palpating the abdominal tuck, ribs, waist and the dorsal spinous processes at the 
base of the tail. Figure 4.4 gives an illustration of the different BCS of dogs. 
 
The Association for Pet Obesity Prevention (APOP) in the US described the BCS as follows: 
 
BCS 1 – Emaciated  
Visually evaluating a dog from the side with a BCS of 1, one will clearly notice a severe 
abdominal tuck, including the spine, ribs, hip bones and bone protrusions. The dog has lost 
muscle mass with no observable fat cover. 
 
BCS 2 – Thin 
The spine, ribs, hip bones and bone protrusions are easily felt with minimum body fat. An 
abdominal tuck will still be noticeable from the side. 
                                                          
 See Annexure D 
† See Annexure C 
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BCS 3 – Ideal 
The spine, ribs and hip bones are felt easily but are not always seen. There is a thin layer of 
body fat covering the bones. Prominence of bone can still be felt and an abdominal tuck can 
still be visually seen from the side as well as a proportioned lumber waist. This is the ideal 
body condition and the dog often has a muscular appearance. 
 
BCS 4 – Overweight 
The spine, ribs and hip bones are difficult to feel with a moderate amount of body fat. The 
abdomen sags and no abdominal tuck can be viewed from the side. There is a moderate 
amount of fat deposits on the tail base, hips and chest. 
 
BCS 5 – Obese 
The spine, ribs and hip bones are difficult to feel with large fat deposits on the tail base, back 
and chest. There is a prominent abdomen sag with a ventral base and no waist is visible from 
the side. The back is visually broadened from above and the chest appears to be swollen. 
 
 
 
 
 
 
 
 
Figure 4.4 The body condition score of dogs (source: 
http://dawgbusiness.blogspot.co.za/2011/11/are-zombies-biggest-threat-to-your-dog.html) 
 
4.3 Blood samples 
Blood samples were collected in the seven major townships and welfare organisations, 
namely the AACL, the AWS (PE) and Save-a-Pet Rehabilitation Centre.  
 
Samples consisted of serum samples (yellow and red top sterile vacutainer™ tube) and 
heparinized blood samples (green top heparinized vacutainer™ tube). These samples were 
randomly collected from dogs during routine rabies vaccination campaigns in the study area. 
Samples were collected as the dogs arrived for vaccination, they had the choice to freely 
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participate in the study until enough samples were collected for the specific area. All blood 
samples collected were taken according to the guidelines prescribed by the OIE (OIE, 2008: 
OIE, 2013). Samples were collected from the cephalic vein located in the front leg of the 
dog using an 8 ml syringe, allowing control of the amount of vacuum applied, and a 25mm 
precision glide™ 20 gauge needle. The cephalic vein is easier to access than the jugular vein 
and is a relatively large vein, reducing the risk of the vein collapsing. Dogs with short hair 
was swabbed with 70% alcohol at the site of venepuncture before the blood sample was 
collected. Dogs with long hair were shaved at the venepuncture site before swabbed with 
70% alchohol.  
 
The blood collected was transferred into the vacutainer™ tube to prevent haemolysis. The 
method used for transferring the blood was by first removing the needle from the syringe, 
preventing fluidic shear or turbulence experienced by cells passing through the needle, and 
then depositing the blood in the vacutainer™ after the lid has been removed. From the 
sample collected, 4 ml blood was deposited into a 10 ml green top heparinised and 4 ml in 
a 10ml red top sterile vacutainer™ tube. All blood samples were marked with the number 
allocated to the specific animal. The samples were carefully packaged, labelled and 
transmitted to the laboratory by the fastest practicable method, with the appropriate 
temperature control.  
 
The sterile blood sample in the red top vacutainer tube was left for three hours to clot and 
then centrifuged at 2800 r.p.m for 15 minutes. The serum was then removed and stored in 
test tubes at -20°C for 2ME-TAT.  
 
Heparinized blood samples in green heparinized vacutainer test tubes were submitted to the 
Stellenbosch Laboratory, as is, for AGID culture to verify reactors on 2ME-TAT.  
 
All heparinized blood samples and serum samples were collected aseptically and packed in 
sterile containers, sealed and marked with an identifier number and transported according to 
OIE protocol for transporting infectious agents (OIE, 2012), to the OVI in Pretoria for 
analysis.  
 
 34 
 
4.4 Serology 
The TAT is used as serological test in the diagnosis of B. canis with the CFT as confirmation. 
The TAT can have false positive reactions and it is difficult to interpret the results with early 
sera and sera from chronically infected dogs. According to the CFSPH, cross-reactions can 
occur between other micro-organisms and the Brucella organism in various serological tests. 
Bearing in mind that the TAT is not a very specific test, although it has the advantage of 
being semi-quantitative, a CFT was used as confirmation on the positive results obtained 
from the TAT. The CFT was used as a confirmation test on 35 positive samples, 18 negative 
samples and 2 reactors. All the negative samples from the TAT were randomly selected.  
 
The TAT is an agglutination test carried out in a test tube for identification of bacteria and 
a positive reaction will consist of a clearing of a prior opalescence (Studdert et al., 2011). 
The agglutination of red blood cells or bacteria is usually in response to a particular antibody. 
The antibody in the serum and its titre can be determined according to its relative 
agglutination amount.  
 
 
 
 
 
 
 
 
 
Figure 4.5 Tube Agglutination Test results two days after incubation 
 
The stages of the CFT transpire from when the antigen and compliment are added, until the 
final reading takes place. If an antibody was present in the serum, the compliment will be 
fixed due to the Ag-Ab complex. If no antibody is present in the serum, the compliment 
remains free. Sensitized sheep red blood cells (SRBC), together with antibodies against 
SRBCs, are added in order to determine whether the compliment has been fixed (Alton et 
al., 1988; Giri, 2015). 
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4.4.1 Laboratory procedures 
Laboratory procedures were performed according to standard protocols (OIE, 2013) and the 
Laboratory’s Standard Operating Procedures for the handling of infectious material and tests 
in the Agricultural Research Council – Onderstepoort Veterinary Institute (ARC – OVI) 
(Potts et al., 2015; Potts & Lӧtter, 2014). Procedures included the TAT and CFT. 
4.4.1.1 Brucella canis 2ME-TAT 
The TAT is used for testing the canine samples collected to determine if there are B. canis 
antibodies present in the serum. These tests were carried out at the ARC-OVI in 
collaboration with the laboratory technicians (Potts et al., 2015; Potts & Lӧtter, 2014). The 
principle of this test is that when a serum sample contains antibodies against B. canis, an 
agglutination complex will form between the Ag-Ab. This agglutination will lead to a 
clearing of the liquid in the test tube. When the serum sample does not contain antibodies 
against B. canis, the liquid will remain opaque.  
 
Presented below are a detailed outline of the equipment and materials used, test procedure 
and appendices of the TAT laboratory procedures (Source: Potts & Lӧtter, 2014; Staak, 
2000; Alton et al., 1988; ISO/IEC, 2005; OIE, 2004). 
 
A. EQUIPMENT AND MATERIALS USED 
 
i. Pipettes and pipette tips, 10 µl to 1000 µl  
ii. B. canis high titre positive control serum (NVSL reagent 212-H) 
iii. B. canis medium titre positive control serum (NVSL reagent 212-M) 
iv. B. canis negative control serum (NVSL reagent212-N) 
v. B. canis tube agglutination antigen (NVSL reagent 17) 
vi. B. canis tube test diluent 
vii. Incubator, 37 ± 1 °C 
viii. ME (2-mercaptoethanol) solution 
ix. Test tubes and racks for tubes 
x. pH Meter 
xi. Timer 
xii. Eye protection, gloves 
xiii. Graduated cylinder, 100 ml 
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xiv. Refrigerator, 4 ± 3 °C 
xv. Sodium hydroxide, 0.5 N 
xvi. Water, distilled 
 
B. TEST PROCEDURE  
(a) Reagents 
The ME solution as well as the undiluted antigen used was stored at 4°C ± 3°C, and would 
have remained useable until the expiration date. However, the Lyophilized control sera can 
be stored indefinitely at 4°C ± 3 °C. The control sera were reconstituted with distilled water 
by using a volume that is equal to the volume indicated on the label. Control sera that were 
rehydrated were stored at 4°C ± 3°C and can remain useable as long as the sera performed 
as expected. 
 
(b) Controls 
Every batch of samples that were to be tested was run with an antigen control, high and 
medium titre positive controls and a negative control. 
 
(c) Procedure 
(i) Screening test 
The test tubes were labelled separately, using the number allocated to the individual dog. 
The control serum and antigen control tubes were all labelled separately. In preparation of 
the controls, 40 μl of both the positive or negative control serum was dispensed into the 
relevant tube separately. No sample was required for the antigen control. By using a 1000 
µl Pipette, the ME solution and the working dilution of antigen was added to each tube, 
including the controls. The antigen was mixed constantly to dissolve any precipitate before 
use. The final dilution, together with the ME solution and antigen within the test tube, was 
1:50. The contents in the tubes were then mixed by tilting the tube and then incubated at 
37°C ± 1°C for 48 ± 3 hours. The test was red with the control sera by holding the tubes up 
to a light to make visualization easier. All the samples that tested suspicious and/or positive 
in the screening test, needed to be tested in the full test. A BS/RT 040 form was filled in 
with all the relevant data. 
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(ii) Full test 
With the full test, three tubes were labelled (1:50, 1:100 and 1:200) for each sample, and the 
control serum including the antigen control. 40 μl (1:50 tube), 20 μl (1:100 tube), and 10 μl 
(1:200 tube) of the sample or positive or negative control serum was dispensed into the 
respective sets of tubes. A separate tip was used for each serum tube. The antigen control 
did not require a sample to be added. 
 
1000 µl of ME solution and working dilution of antigen was added to each tube, including 
the antigen control tube. The antigen was mixed to dissolve any precipitate before use. The 
contents in the tubes were mixed by tilting the tube, and then incubated at 37°C ± 1°C for 
48 ± 3 hours. The test was red with the control sera by holding the tubes up to a light to 
make visualization easier.  The tubes were evaluated by the amount of clearing in the tube 
from 1 (slight) to 4 (complete). All the information and results were recorded on a BS/RT 
040 form. 
 
C. APPENDICES 
 
(a) Preparation of the antigen working dilution 
A working dilution of antigen was prepared by combining 4.4 ml of undiluted antigen with 
95.6 ml of B. canis tube test diluent. The pH of the diluted antigen was measured and 
adjusted to 8 – 9.5 (inclusive) using 0.5 N sodium hydroxide when necessary. 
The auto-agglutination will indicate that the pH of the antigen is low. The antigen working 
dilution was stored at 4ºC ± 3°C and was useable for as long as the reaction of the serum 
and antigen controls was valid. 
 
(b) Formulas 
(i) Saline (0.85%) with 10% formaldehyde 
• NaCl 0.85 g 
• Formaldehyde (37% - 40%) 10 ml 
• Distilled H₂O, QS to 100 ml Write in full 
• Combine ingredients, mix until in solution and QS to 100 ml. Store for up to six 
months at room temperature (20°C – 26°C). 
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(ii) Brucella canis tube test diluent  
Saline (0.85%) with 10% formaldehyde 24 ml  
• NaCl 139.2 g 
• Distilled H₂O, QS to 4 litres 
• Combine ingredients; mix until in solution and QS to 4 litres. Store for up to six 
months at room temperature (20 - 26 °C).  
 
(iii) ME solution 
• Add 0.715 ml of 2-mercaptoethanol to 99.3 ml of B. canis tube test diluent and mix 
by stirring. Adjust pH to 8.0 – 9.5 with 0.5 N sodium hydroxide and store at 4°C ± 
3°C. It is useable for as long as the serum and antigen controls are valid. 
• The ME solution may be used immediately. If the test has failed, repeat after the ME 
solution has been held at 4°C ± 3°C for a minimum of 24 hours. 
• A chemical fume hood must be used during the dilution of the 2-mercaptoethanol. 
• When handling concentrated 2-ME or 0.5 N sodium hydroxide, eye protection and 
gloves must be worn. 
 
4.4.1.2 Compliment Fixation Test 
Presented below are a detailed outline of the principle, equipment, materials, reagents, test 
procedure, quality control and forms of the CFT laboratory procedures (Source: Potts & 
Lӧtter, 2014; Potts et al., 2015; Staak, 2000; Alton et al., 1988; ISO/IEC, 2005; LQWG, 
2007; OIE, 2004). 
 
A.  PRINCIPLE 
 
The compliment system is a complex series of proteins and if activated by an antigen-
antibody complex, it will react in a sequential manner causing cell lysis. In the first stage 
of the CFT, the test serum and antigen were mixed with normal guinea pig serum 
(compliment). In the second stage of the CFT, the indicator or haemolytic system was 
added to the mixture. The haemolytic system added consists of SRBC that have been 
sensitised using anti-sheep red blood cell antibody (haemolysin). In the case were the test 
serum contains B. ovis antibodies, the compliment will be fixed and will not be able to 
react in the haemolytic system, resulting in a positive reaction. In this case, no lysis of 
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SRBC will occur and thus will remain intact, resulting in a positive reaction. Conversely, 
if the serum does not contain antibodies against B. canis, the compliment will not be fixed 
and lysis will occur with the SRBC, resulting in a negative reaction. 
 
B.  EQUIPMENT 
 
i. Multi-channel micropipette (5 µl to 50 µl/300 µl) and single channel micropipette 
(10 µl to 100 µl/1000 µl; 1 – 10ml) 
ii. Incubator (37⁰C ± 2⁰C) 
iii. Timer 
iv. Refrigerator (4⁰C ± 2⁰C), Freezer (-20⁰C ± 5⁰C) 
v. Water bath (37⁰C ± 2⁰C and 58⁰C ± 2⁰C) 
vi. Centrifuges (1 Standard, 1 to spin microtiter plates) 
vii. Dispenser (25 µl to 50 µl) 
viii. Shaker 
ix. X-ray viewing box or magnifying mirror 
x. Spectrophotometer or Wintrobe tubes 
xi. Biological safety cabinet 
xii. Balance 
xiii. Thermometers 
xiv. Magnetic stirrer 
xv. Pasteur pipettes 
 
C.  MATERIALS 
 
i. Permanent marker pen 
ii. Test tubes 
iii. Pipette tips 
iv. Beaker 
v. 96-well microtiter plate filled with 1.2 ml polypropylene cluster tubes  
vi. 96-well U-bottom microtiter plates 
vii. Reagent bottles and reservoirs 
viii. Centrifuge tubes 
 40 
 
ix. Measuring cylinders 
x. Wintrobe tubes 
xi. Sealing film or plate lids 
 
D.  REAGENTS 
 
i. B. ovis antigen  
ii. Positive B. ovis sera 
iii. B. ovis negative sera  
iv. Guinea pig Compliment for CFT- ORAY®  
v. Amboceptor from rabbit- ORLC®  
vi. Veronal buffer - Virion®  
vii. 3% Sheep red blood cell suspension 
viii. Test Sera 
 
E.  TEST PROCEDURE 
 
The inactivation of test serum was carried out in a 96-well, U-bottom microtiter plate filled 
with 1.2ml polypropylene cluster tubes. The test serum was inactivated by using a water 
bath at 62°C ± 2°C for 30 minutes before the test is run. The water level covered the level 
of the serum and after inactivating the sera, it was set aside to cool down before 
commencing with the test. 
 
The CFT was carried out in 96-well, U-bottom microtiter plates. Positive and negative 
controls were used in separate wells on each plate. 25 µl Veronal buffer saline (VBS) was 
dispensed to all the wells beginning from row B, proceeding to row H (columns 1-8). For 
each microplate used, the positive control sera were used in row B (column 1), negative 
control sera were used in row B (column 2) and the test sera was used in row B (column 3-
8). 
 
25 µl of inactivated serum was transferred from the inactivated serum microtiter plate. The 
serum was dispensed into row B (column 1-8) by using an 8-channel micropipette. The CFT 
buffer was mixed with the serum in row B (column 1-8) and 25 µl volume of serum was 
drawn up, making serial doubling dilutions from row B-H (column 1-8). The last 25 µl 
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volume from row H (column 1-8) was discarded. These dilutions accomplished a 1/2 serial 
dilution, and produced dilutions of 1/4, 1/8, 1/16, 1/23, 1/64 and 1/128 from rows C – H 
(column 1-8). 
 
25 µl B. ovis antigen was dispensed at working dilution into row C-H (column 1-8), and 25 
µl VB was dispensed into row B (column 1-8). 25 µl compliment was added at working 
dilution to all the wells from row B – H (column 1-8).  
 
Plates were incubated at 37°C for 30 minutes. Plates were then placed next to each other 
allowing uniform heat distribution. After incubation, 50 µl of haemolytic system was 
added to all the wells from row B – H (column 1-8). Plates were placed on a shaker and 
incubated for a further 30 minutes at 37°C. After incubation, plates were read over a 
magnifying mirror or X-ray viewing box. 
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Table 4.2.3 The conversion of CFT endpoint reactions to IUml⁻¹ on a scale where 50% 
haemolysis in a 1/220 serum dilution is equivalent to 1000 IUml⁻¹ 
Row 
Serum 
Dilutionᵃ 
Final 
Dilutionᵇ 
Endpoint Reading IU ml-1ᶜ 
SAU ml-1ᵈ % Haemolysis Reaction 
C 1/4 1/20 100 
75 
50 
25 
0 
0 or- 
1 or + 
2 or ++ 
3 or +++ 
4 or ++++ 
0 
15 
18 
21 
24 
D 1/8 1/40 75 
50 
25 
0 
1 or + 
2 or ++ 
3 or +++ 
4 or ++++ 
30 
63 
43 
49 
E 1/16 1/80 75 
50 
25 
0 
1 or + 
2 or ++ 
3 or +++ 
4 or ++++ 
60 
72 
86 
98 
F 1/32 1/160 75 
50 
25 
0 
1 or + 
2 or ++ 
3 or +++ 
4 or ++++ 
120 
145 
172 
196 
G 1/64 1/320 75 
50 
25 
0 
1 or + 
2 or ++ 
3 or +++ 
4 or ++++ 
240 
290 
344 
392 
H 1/128 1/640 75 
50 
25 
0 
1 or + 
2 or ++ 
3 or +++ 
4 or ++++ 
480 
581 
688 
784 
 1/220  1/1100 50 2 or ++ 1000 
a  Serum dilution = dilution factor with veronal buffer only 
b  Final dilution = final dilution factor after all reagents were added 
c  IU ml-1 = International Units per millilitre 
d  SAU ml-1 = South African Units per millilitre 
 
F.  QUALITY CONTROL 
Each microplate of serum tested was run with positive and negative controls.  
 
G. FORMS 
All raw data forms pertaining to the test are to be filed and retained for a minimum of five 
years.  
 43 
 
CHAPTER 5 
RESULTS AND DISCUSSIONS 
 
5.1 Laboratory tests 
5.1.1 Tube Agglutination Test 
A screening TAT was performed on all 400 sera samples. Agglutination was observed two 
days after incubation of the first TAT, which showed agglutination to 61 (15.25%) sera 
samples reacting positive for B. canis. A 2ME-TAT was conducted on the 61 reactors at 
lower dilutions to eliminate the non-specific agglutins (false positive reactors) which reacted 
to the B. canis antigen. Agglutination was observed two days after the second 2ME-TAT. 
The amount of clearing in the tube was evaluated from 1 (slight) to 4 (complete), indicating 
that the fluid phase of 23 samples was not clear, which indicated that these samples were 
false positive reactors. However, 38 samples showed agglutination of incomplete and 
complete reactions to the B. canis antigen.  
 
In Table 5.1, the tube titre results showed that 11 suspicious sera samples had an incomplete 
(1, 2, or 3) reaction at the 1:50 dilution and 1 at the 1:100 dilution. Results at the 1:200 
dilution showed that 15 sera samples had an incomplete (2 or 3) reaction and 11 sera samples 
had a complete (4) reaction. 
 
 
 
 
 
 
 
 
 
 
 
                                                          
 See Annexure B 
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Table 5.1.4 Positive 2ME-TAT Results of all the TAT positive reactors 
Area 
Screening TAT 
Positive Reactors 
TAT 
1/50 1/100 1/200 
Kwa-Zakhele 2   4+ 
8   3+ 
29   3+ 
39 3+   
Zwide 45   4+ 
54   4+ 
62   4+ 
67   4+ 
77  2+  
80 2+   
81   3+ 
87 2+   
New Brighton 100   3+ 
101 1+   
111   3+ 
115 2+   
Kwa-Dwesi 155 2+   
163 2+   
Motherwell NU 29 198   3+ 
199 3+   
200 3+   
208   4+ 
210   4+ 
234   4+ 
Motherwell NU 13 257   2+ 
271   4+ 
273   3+ 
280   3+ 
299   4+ 
301   2+ 
303   4+ 
305   2+ 
Save-A-Pet 315   2+ 
326 2+   
Walmer 371   3+ 
373 3+   
383   3+ 
AACL   396   3+ 
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Figure 5.1 Presents the results of the screening TAT indicating the reactors and the 2ME-
TAT revealing the positives and negative results. 
 
 
Figure 5.1 Visual representation of the 2ME-TAT results of the survey areas 
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In Figure 5.1, the green bars represent the negative samples of each area, the blue bars 
represent the reactors and the red bars represent the positive samples. Zwide and Motherwell 
NU 13 both had high reactor percentages and high positive percentages. Save-A-Pet had 
high reactor percentages, but low positive percentages. KwaMagxaki had reactors, but no 
positives and AWS (PE) had no reactors and no positives. 
 
5.1.2 Compliment fixation test 
Fifty-six sera samples were tested with the CFT. The 56 samples consisted of 36 positive 
2ME-TAT reactors, 18 negative TAT reactors and two false negative 2ME-TAT reactors. 
 
The results of the CFT showed that out of the 56 samples, 16 were negative where there was 
no sedimentation of SRBC present (complete haemolysis). The positive result of 40 samples 
had a distinct red button at the bottom of the well where sedimentation of SRBC was present. 
The final dilution of these positive tests was determined when 50% sedimentation occurred 
in a dilution, showing that 24 samples had 0% haemolysis, 12 samples had 25% haemolysis 
and four samples had 75% haemolysis. 
 
5.1.2.1 CFT results 
Using the prescribed conversion chart in Table 4.2, the endpoint reactions were converted 
to international units/ml (IUml⁻¹), and the result analysis is presented in Table 5.2. 
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Table 5.2.5 Compliment Fixation Test Results 
Serum 
Sample 
Serum 
Dilution 
Final 
Dilution 
Endpoint Reading IU ml-1 
SAU ml-1 % Haemolysis Reaction 
2 1/128 1/640 0 4 or ++++ 784 
8 1/128 1/640 25 3 or +++ 688 
29 1/32 1/160 0 4 or ++++ 196 
39 1/8 1/40 0 4 or ++++ 49 
45 1/128 1/640 25 3 or +++ 688 
54 1/128 1/640 25 3 or +++ 688 
62 1/32 1/160 25 3 or +++ 172 
67 1/128 1/640 0 4 or ++++ 784 
77 1/32 1/160 25 3 or +++ 172 
80 1/16 1/80 25 3 or +++ 86 
81 1/16 1/80 25 3 or +++ 86 
87 1/32 1/160 0 4 or ++++ 196 
100 1/16 1/80 0 4 or ++++ 98 
101 1/16 1/80 0 4 or ++++ 98 
115 1/16 1/80 0 4 or ++++ 98 
143 1/8 1/40 75 1 or + 24 
155 1/8 1/40 75 1 or + 24 
163 1/32 1/160 25 3 or +++ 172 
198 1/64 1/320 0 4 or ++++ 392 
199 1/128 1/640 0 4 or ++++ 784 
200 1/32 1/160 25 3 or +++ 172 
208 1/128 1/640 0 4 or ++++ 784 
210 1/64 1/320 0 4 or ++++ 392 
213 1/8 1/40 75 1 or + 24 
234 1/128 1/640 0 4 or ++++ 784 
240 1/8 1/40 0 4 or ++++ 49 
243 1/8 1/40 25 3 or +++ 43 
244 1/8 1/40 75 1 or + 21 
257 1/64 1/320 0 4 or ++++ 392 
271 1/64 1/320 0 4 or ++++ 392 
280 1/64 1/320 25 3 or +++ 344 
287 1/32 1/160 0 4 or ++++ 196 
301 1/16 1/80 0 4 or ++++ 98 
303 1/128 1/640 0 4 or ++++ 784 
305 1/128 1/640 0 4 or ++++ 784 
326 1/32 1/160 0 4 or ++++ 196 
371 1/128 1/640 0 4 or ++++ 784 
373 1/32 1/160 0 4 or ++++ 196 
383 1/16 1/80 25 3 or +++ 86 
396 1/128 1/640 0 4 or ++++ 784 
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In Figure 5.2, the results shows that of all the samples tested, nine sera samples showed a 
maximum antibody titre of 784 IU/ml with 0% haemolysis, and three sera samples showed 
a serological reaction of 688 IU/ml with 25% haemolysis. A final dilution of 1/320 showed 
that four sera samples had a reaction of 392 IU/ml with 0% haemolysis, and one reacted at 
344 IU/ml with 25% haemolysis. A final dilution of 1/160 showed that five sera samples 
had titres of 192 IU/ml with 0% haemolysis and four had titres of 172 IU/ml with 25% 
haemolysis. At a final dilution of 1/80, four sera samples had titres of 98 IU/ml with 0% 
haemolysis and four had titres of 86 IU/ml with 25% haemolysis. A final dilution of 1/40 
showed that two sera samples had titres of 49 IU/ml with 0% haemolysis and one had a titre 
of 43 IU/ml with 25% haemolysis.  
 
A visual representation is given in Figure 5.2 showing the endpoint reactions to the CFT. 
 
 49 
 
 
Figure 5.2 Visual representation of the CFT endpoint reactions to the IU ml-1 indicating 
the positive results of the samples tested 
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All the positive samples of the TAT tested positive with the CFT. The negative samples that 
showed a reaction with the CFT were samples 213, 240 and 244. However, samples 243 and 
287 were reactors to the screening TAT, but reacted negatively to the 2ME-TAT and showed 
a positive reaction with the CFT. Sample number 287 had a titre of 196 IU/ml, while sample 
number 213, 240, 243 and 244 had a titre of 43 IU/ml and lower. Stable or decreasing titres 
indicated that the animals might not currently be actively infected with B. canis. 
 
5.1.2.1 Prevalence rate  
Figure 5.3 shows the prevalence rate of the samples collected of B. canis within NMBM 
(PE). 
 
 
Figure 5.3 Prevalence rate of the samples collected within NMBM (PE) 
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The results of the CFT showed that there were positive reactions of samples that tested 
negative with the TAT. Therefore, the prevalence rate of each area was determined by 
combining both the TAT and CFT results. 
 
Serological results indicated townships to have an overall prevalence of B. canis of 10.28% 
with zero-prevalence in KwaMagxaki, while KwaDwesi which is situated right next to 
KwaMagxaki (Figure 4.2) had a 5.1% positive prevalence. Situated not too far south from 
KwaMagxaki lies Zwide, which showed a conclusive extremely high prevalence of 16%, 
the highest prevalence of all the townships sampled. With these results, there is a possibility 
that KwaMagxaki is not 100% negative for B. canis. It is therefore evident that B. canis is 
present in the townships with the potential of spreading through uncontrolled and stray dogs, 
without the owners’ knowledge. In Motherwell, it is clear that the disease has spread more 
widely in NU 13 with a prevalence of 15% than in NU 29 that has a prevalence of 9.8%. It 
is also possible that the disease entered Motherwell from the South and spread to the 
Northern parts. However, an extensive survey will need to be conducted in order to not only 
track the source of entry but also the spread of the B. canis infection.  
 
At the welfare organisations, the prevalence rate was established at 6%, but even though it 
was not as high as that of the townships, there is still a possibility of the dogs spreading the 
disease. Dogs sharing a kennel with an infected dog have a high risk of contracting the 
disease, as well as the dog that is housed directly next to the infected dog. Even though the 
AWS (PE) did not have any positive reactors from the 20 dogs sampled, there is still the 
possibility of dogs being infected with B. canis. Walmer is situated not too far from the 
AWS (PE) where positive reactors have been found and this could give rise to the possibility 
that there might be B. canis infected dogs brought into the AWS (PE) from that area. 
 
Combined serological results conclude that the prevalence rate in the study area of the 
NMBM is 9.75%. Even though B. canis antibodies were detected mostly in the serum 
obtained from dogs in the townships, the antibodies were also found at the welfare 
organisations. KwaMagxaki and the AWS (PE) had 0% prevalence, but they are still 
closely surrounded by areas (Figure 4.2) positive with B. canis bacteria. All suspect 
reactions should be retested within 30 – 60 days. Stable or decreasing titres indicated that 
the animals might not currently be actively infected with B. canis.  
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Objectives 
According to the TAT, 2ME-TAT and CFT the results obtained indicated that the 
prevalence rate for the seven townships, the three welfare organisation, and the NMBM 
(PE) was established and the objectives was met. 
 
5.2 Questionnaires  
 
 Four hundred questionnaires were completed and collected with the blood samples 
collected from each individual dog. Questionnaires and samples randomly collected 
consisted of 350 samples from the townships and 50 samples from welfare organisations. 
These questionnaires were used to collect information on the dogs’ status and health. The 
survey questions consisted of open-ended and closed-ended questions. 
 
The questionnaires provided information not only on the general status of the dogs in the 
individual townships and welfare organisations, but also on the general health status. Dogs 
in the townships were only vaccinated against rabies, because of the rabies campaigns, but 
received no other vaccinations. It was made clear when completing the questionnaire that 
the owners were not aware of any other vaccinations that should be administered. In this 
regard, the dogs might look healthy, but their disease status is truly unknown.   
 
Due to the large amount of data collected, charts and tables were used as illustrations. A 
simple bar chart is used to visually present the results of data collected to display counts or 
frequencies of the categories of a nominal or ordinal variable. Counts or frequencies are 
displayed in percentages to be statistically significant. 
 
5.2.1 Data collected within the townships 
Seven townships of NMBM (PE) were part of the township survey. Motherwell is the 
biggest township in PE and samples were thus collected in Motherwell NU 29 and 
Motherwell NU 13. These two areas are independent from each other and there is no 
relationship between the participants in the areas within Motherwell. Motherwell NU 29 and 
Motherwell NU 13 were independent of observations. Sample sizes are indicated in Table 
5.3. 
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Table 5.3.6 The sample size of the population within each township  
Township Sample size 
KwaZakhele 40 
Zwide 50 
New Brighton 40 
KwaMagxaki 20 
KwaDwesi 39 
Motherwell NU29 61 
Motherwell NU13 60 
Walmer 40 
Total 350 
 
There is a noticeable difference between the data collected from the questionnaire and 
sample sizes collected within all the independent areas sampled. Samples collected varied 
from 20 to 61 in respective areas. Only 20 samples were collected from KwaMagxaki due 
to no residents being in that area at that time, and from Motherwell NU 29 and NU 13, 60 
samples were collected. 
 
5.2.1.1 Gender 
Figure 5.4 shows the gender status in the researched area. 
 
Figure 5.4 The ratio of male:female dogs sampled in the townships 
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The gender bar chart provides information regarding the male and female relation in the 
different townships. In Zwide, KwaDwesi, Motherwell NU 29 and Motherwell NU 13, the 
proportion of male and female was almost equal. Female dogs sampled outnumbered the 
males in Walmer by 25% and in New Brighton by 35%. In KwaZakhele and KwaMagxaki 
more male dogs than females were sampled with a 35% and 60% difference, respectively.  
 
Even though the total population difference between male and female dogs was only 7.25%, 
the male dog population was higher at 53.8% and the female dog population was lower at 
46.2%. 
 
5.2.1.2 Desexing status 
Figure 5.5 shows the neutered or spayed status in the research area. 
 
 
Figure 5.5 The relationship of dogs that have been neutered or spayed and dogs that have 
not been neutered or spayed in the townships 
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In the townships KwaMagxaki and KwaDwesi there are no owned free-roaming dogs. But, 
KwaMagxaki still had 95% dogs that have not been neutered or spayed and KwaDwesi had 
72%. 
 
With regard to Motherwell, which was divided in two separate independent areas, NU 13 
had 12% neutered or spayed dogs while NU 29 only had 3%. 
 
5.2.1.3 Breed size 
Figure 5.6 shows the breed size status in the researched area. 
 
 
Figure 5.6 The breed size of dogs in the townships 
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Table 5.4.7 The frequency of 350 dogs’ BCS in Port Elizabeth townships 
Township 
BCS 
Total 
1 2 3 4 5 
Kwa-Zakhele 2 26 12 0 0 40 
Zwide 0 23 24 3 0 50 
New Brighton 3 15 20 2 0 40 
KwaMagxaki 0 1 19 0 0 20 
KwaDwesi 0 2 37 0 0 39 
Motherwell NU29 0 22 38 1 0 61 
Motherwell NU13 0 12 43 5 0 60 
Walmer 0 1 38 1 0 40 
Total      350 
 
In the frequency table, the BCS were used to obtain an estimate of the general health status 
of the dog population in the townships. As described in chapter 5, point 5.2.1, the BCS were 
assessed by making use of a numeric scale from 1 – 5. In Table 5.4, the scale is represented 
as the number of dogs that have the same BCS in the specific township. It is clear that within 
KwaMagxaki, KwaDwesi and Walmer Township the majority of the dog population has a 
BCS of 3. On the other hand, the general dog population in KwaZakhele was underweight 
with the majority of the dogs assessed having a BCS of 2. 
 
5.2.1.5 Dogs per household   
Table 5.5 indicates the number of dogs per household of each individual dog that 
participated in this study. 
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Table 5.5.8 The frequency of the number of dogs per household in Port Elizabeth 
townships 
Township 
Dogs per household 
1 2 3 4 5 
Kwa-Zakhele 17 16 5 2 0 
Zwide 24 13 12 0 1 
New Brighton 22 7 7 3 1 
KwaMagxaki 11 8 1 0 0 
KwaDwesi 14 10 13 2 0 
Motherwell NU29 37 12 9 1 2 
Motherwell NU13 30 26 4 0 0 
Walmer 14 17 4 5 0 
Total 169 109 55 13 4 
 
In Table 5.5, the frequency of the number of dogs per household provided an indication of 
not only the general dog population, but also of the possibility of the B. canis disease 
spreading to other dogs in the same household. 
 
5.2.2 Data collected from the welfare organisations 
Only three welfare organisations took part in the survey in the NMBM (PE). These three 
welfare organisations are independent from each other and there is no relationship between 
the participants in either of the organisations in NMBM (PE). Save-A-Pet Rehabilitations 
centre, AWS(PE) and the AACL were independent of observations. 
 
5.2.2.1 Sample size 
Table 5.6 indicates the sample size of the dogs that participated in each township. 
 
Table 5.6.9 The sample size of the population in each township of Port Elizabeth 
Township Sample size 
Save-A-Pet 20 
AWS (PE) 20 
AACL 10 
Total 50 
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5.2.2.2 Gender 
Figure 5.7 shows the gender status in the researched area. 
 
 
Figure 5.7 The ratio of male:female dogs sampled in the welfare organisations 
 
The gender bar chart provides information regarding the male and female relation in the 
different welfare organisations. At Save-A-Pet and the AWS(PE) the housed dogs were used 
for the sampling and at the AACL dogs were sampled when they were brought to the clinic. 
Although there were 70% female dogs at Save-A-Pet, it does not necessarily mean that there 
are more female dogs than male dog at the centre. Only 20 dogs were randomly selected out 
of all the dogs at the rehabilitation centre and therefore it cannot provide a reasonable 
estimation on the gender relation. The AACL also had 70% female dogs and only 30% male 
dogs, which in turn can give an estimation on the general gender preferences of the 
surrounding area. 
 
5.2.2.3 Desexing status 
Figure 5.8 shows the neutered or spayed status in the research area. 
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Figure 5.8 The relationship of neutered/spayed and not neutered/spayed dogs in the 
welfare organisations 
 
At the AWS (PE) 80% of the dogs are neutered or spayed and the other 20% are most likely 
to be new dogs that has have been declared unclaimed dogs. All the dogs at Save-A-Pet were 
neutered or spayed, but none of the outside dogs at AACL. 
5.2.2.4 Breed size 
 
Figure 5.9 shows the breed size status in the researched area. 
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Figure 5.9 The breed size of dogs at the welfare organisations 
 
As with the townships of the NMBM, the general breed size at the welfare organisations 
were also medium size. However, there were more purebred dogs at Save-A-Pet and the 
AWS (PE) than in the townships, whereas the majority of the dogs at the AACL were 
crossbred dogs. The breed size of the dogs at AACL gives an estimate of the general breed 
size in the surrounding area, seeing that all the dogs sampled were brought into the clinic. 
The same can be said of Save-A-Pet due to the location of the centre on Figure 4.2 in chapter 
4. In addition, the AWS (PE) is situated on the outskirts of PE itself and it stands to reason 
that a wider variety of types of breeds affects the breed size. 
 
5.2.2.5 Body Condition Score 
Table 5.7 indicates the BCS of dogs that participated in this study. 
 
Table 5.7.10 Frequency of 50 dogs’ BCS at the welfare organisations in Port Elizabeth 
 Body Conditioning Scores (BCS)  
Township 1 2 3 4 5 Total 
Save-A-Pet 0 0 12 7 1 20 
AWS (PE) 0 3 16 1 0 20 
AACL 0 2 4 4 0 10 
Total      50 
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At Save-A-Pet, 60 % of the dogs were assessed to have a BCS of 3, 35% a BCS of 4 and 
10% a BCS of 5. At the AWS(PE), 15% were assessed to have a BCS of 2, 80% a BCS of 3 
and 5% a BCS of 4. Of the outpatient dogs from the AACL, 20%were assessed to have a 
BCS of 2, 40% a BCS of 3 and 40% a BCS of 4.  
 
Objective 
According to the results obtained indicated that the general status of dogs with regard to 
the neutered/spayed dogs, male/female dogs and the body condition score of all the dogs 
sampled in the NMBM, was met. 
 
5.3  Nelson Mandela Bay Metropolitan (Port Elizabeth) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10 Visual presentation of the differences in the frequencies or percentages of the 
categories within NMBM 
 
Figure 5.10 is classified into four groups subjected to analysis within the survey conducted. 
Results are recorded as true results, due to the fact that the true dog population sample size 
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in the study area was known. Even though KwaMagxaki and the AWS (PE) was both 
regarded as “outliers” due to the fact that they had a 0% prevalence rate, they were not 
excluded from the results. The variables used for statistical analysis are the gender, neutered 
or spayed dogs, and positive and negative results of B. canis infection in NMBM (PE). 
 
The gender result of the male and female relation in the NMBM. The random sampling was 
not gender specific in each area. According to the survey, 51% (202) male dogs and 49% 
(198) bitches were sampled out of the 400 dogs sampled.  
 
The neutered/spayed results provide the total number of male and female dogs sampled that 
have been neutered or spayed. As the results show, only 24% (97) of the dogs were neutered 
or spayed and 76% (303) in the survey area were not neutered or spayed. There was 
unfortunately a vast number of dogs that were not neutered or spayed, leading to the 
conclusion that the residents in the survey areas are unaware of the complications involved. 
These complications could be B. canis or various other diseases spreading and the dog 
population growing, which could also lead to more uncontrolled and stray dogs. Even though 
B. canis is transmitted through various ways, neuter and spay campaigns should still be held 
in all the townships to support the residents who cannot afford veterinary costs. If a free-
roaming bitch is in heat, she will go look for a male to mate with, and vice versa, thus 
transmitting and spreading the disease faster. Residents in the townships should be made 
aware of the fact that there is a contagion within their township and that they can also be 
infected with the B. canis bacterium. The residence should be motivated to neuter and/or 
spay their dogs, as well as to keep their dogs securely fenced in on their property to prevent 
their dogs from roaming freely. 
 
The BCS shows that the general condition score of 260 dogs in the survey area was ideal 
(BCS 3), which promoted the health status, but 5 dogs were emaciated (BCS 1) and 110 
dogs were underweight (BCS 2). A total of 24 overweight dogs (BCS 4) were found in the 
townships and welfare organisations and 1 obese dog (BCS 5) were found at the welfare 
organisations. The results from the questionnaire indicate that the dogs participating in this 
survey were in a general healthy condition. However, 28% of the dogs were still classified 
as either emaciated or underweight dogs, and mostly found in the townships. Out of the 39 
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dogs positive for B. canis, only 10 dogs were underweight (BCS 2), 26 dogs were of ideal 
health (BCS 3), and three dogs were overweight (BCS 4). These results indicate that the 
BCS of the dogs does not play any role in the dogs being more susceptible for B. canis 
infection.  
 
The B. canis positive and negative results of the NMBM (PE) showed the proportion 
between the number of dogs that tested either positive or negative for B. canis. Out of the 
400 dogs sampled and serologically tested for B. canis, 39 (9.75%) tested positive and 361 
(90.25%) tested negative. In the 39 dogs found to be seropositive for B. canis, 21 bitches 
tested positive for B. canis of which only six bitches were spayed. In regards to the 18 male 
dogs that tested positive for B. canis, only two male dogs were neutered. It is possible that 
these neutered and spayed dogs were either infected with B. canis before or after they were 
neutered or spayed. However, the fact that B. canis can be transmitted by means of ingestion 
of contaminated reproduction materials and/or secretions from infected bitches cannot be 
ignored. 
 
5.3.1 Statistic analysis 
The two-proportion z-test was used for this study to determine if there is a difference 
between the binomial proportions of two independent groups on a dichotomous dependent 
variable. The z-test determines whether the difference in proportions is statistically 
significant and constructs a 95% confidence interval (CI) of these differences. 
 
The townships and welfare organisations do not have the same sample size, thus results were 
measured in proportions. All statistical analysis was conducted by using the Laerd Statistics 
(SPSS) program.  
 
5.3.1.1 Positive and negative results between the townships and welfare organisations 
Table 5.8 shows a cross-tabulation of the townships and welfare organisations in NMBM 
(PE). 
 
 
                                                          
 See Annexure A 
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Table 5.8.11 B. canis results from the townships and welfare organisations in NMBM 
(PE) 
Cross-tabulation 
Results 
Total 
Positive Negative 
Area 
Townships 
Count 36 314 350 
Expected count 34.1 315.9 350.0 
% within the area 10.28% 89.7% 100.0% 
Welfare organisations 
Count 3 47 50 
Expected count 4.9 45.1 50.0 
% within the area 6.0% 94.0% 100.0% 
Total 
Count 39 361 400 
Expected count 39.0 361.0 400.0 
% within the area 9.75% 90.25% 100.0% 
 
Based on the calculations in table 5.8, 400 dogs were randomly selected for the survey – 350 
dogs in the townships and 50 dogs at the welfare organisations. The proportion of dogs in 
the townships that tested positive for B. canis was 10.28% and the proportion of dogs at the 
welfare organisations that tested positive was 6%. The overall proportion of dogs that tested 
positive for B. canis in the NMBM was 9.75%. 
 
The two-proportions z-test in table 5.9 presents the comparison between the townships and 
welfare organisations as well as the difference between the two proportions. 
 
Table 5.9.12 Two proportions Z-test to do a comparison between the townships and 
welfare organisations in NMBM (PE) 
 Townships 
Welfare 
organisations 
Difference 
Mean (Sample 
proportion) 
0.1028 0.06 0.0428 
95% CI (asymptotic) 0.071 – 0.1346 -0.0058 – 0.1258 -0.0451 – 0.1307 
Z – value 1   
P – value 0.3398   
 
The z-test was performed on the positive result of the townships and the welfare 
organisations. The two-proportions z-test in table 5.9 concludes that the positive results 
(0.1028 (95% CI, 0.071 to 0.1346)) of the townships are higher than the 0.06 (95% CI, -
0.0058 to 0.1258) of the welfare organisations, and the difference in proportions is 0.0428 
(95% CI, -0.0451 to 0.1307), p = 0.3398. 
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Figure 5.11 shows the 95% CI limit of the z-test results between the townships and the 
welfare organisations and the difference between the two proportions. 
 
 
Figure 5.11 The confidence limits of the positive results between the townships and the 
welfare organisations and the difference between the two proportions 
 
The null hypothesis for the above two-proportions z-test is: 
 
H0: P1 = P2 
H0: PTownship = PWelfare organisations 
 
This states that the population proportion in the townships is equal to the population 
proportion in the welfare organisations. This can also be expressed as follows: 
 
H0: P1 – P2 = 0 
H0: PTownship – PWelfare organisations = 0 
 
The null hypothesis states that the difference between the population proportion in the 
townships and the welfare organisations is equal to 0 (zero).  
The alternative hypothesis for the above two-proportions z-test is: 
-0.05
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HA: P1 ≠ P2 
HA: PTownship ≠ PWelfare organisations 
 
The statement above states that the population proportions of the townships and the welfare 
organisations are not equal. This alternative hypothesis equates with the first null hypothesis 
stated. The alternative hypothesis can also be expressed as follows: 
 
HA: P1 – P2 ≠ 0 
HA: PTownship – PWelfare organisations ≠ 0 
 
In this equivalent statement, the alternative hypothesis states that the difference between the 
population proportion in the townships and the welfare organisations is not equal to 0 (zero). 
 
The two-proportions z-test finds evidence against the null hypothesis and calculates the 
significant p-value.  
 
With the above test, there was no statistical significant difference between the two binomial 
independent proportions (p > 0.05). Therefore, we cannot reject the null hypothesis and 
cannot accept the alternative hypothesis (p = 0.3398). 
 
5.3.1.2 Neutered/Spayed results between male and female dogs 
Table 5.10 shows a cross-tabulation of the neutered males and spayed females within 
NMBM (PE). 
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Table 5.10.13 The male and female dogs that were either neutered/spayed or not 
neutered/spayed in NMBM (PE) 
Cross-tabulation 
Neutered/Spayed 
Total 
Yes No 
Gender 
Male 
Count 30 172 202 
Expected count 49.0 153.0 202.0 
% within gender 14.85% 85.14% 100.0% 
Female 
Count 67 131 198 
Expected count 48.0 150.0 198.0 
% within gender 33.83% 66.16% 100.0% 
Total 
Count 97 303 400 
Expected count 97.0 303.0 400.0 
% within gender 24.25% 75.75% 100.0% 
 
Based on the calculations in Table 5.10, 202 male dogs and 198 female dogs were sampled 
in NMBM. The proportion of male dogs that were neutered was 14.85% (30) and the 
proportion of female dogs that were spayed was 33.83% (67). The overall proportion of dogs 
that were neutered/spayed in the NMBM was 24.25% and the proportion not 
neutered/spayed was 75.75%.  
 
The two-proportions z-test in Table 5.11 shows the comparison between the neutered males 
and spayed females as well as the difference between the two proportions. 
 
Table 5.11.14 Z-test to compare between two proportions of the male and female dogs that 
are neutered/spayed in the NMBM (PE) 
 Male - Neutered Female - Spayed Difference 
Mean (Sample 
proportion) 
0.1485 0.3383 0.1898 
95% CI (asymptotic) 0.0995 – 0.1975 0.2724 – 0.4042 0.1058 – 0.2738 
Z – value 4.4   
P – value 0.0001   
 
The z-test was performed between the male and female neutered/spayed results within 
NMBM. From the results of the two-proportions z-test in Table 5.11 it can be concluded 
that the neutered results 0.1485 (95% CI, 0.0995 to 0.1975) of the male dog population is 
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lower than the 0.3383 (95% CI, 0.2724 to 0.4042) spayed results of the female dog 
population, the difference in proportions is 0.1898 (95% CI, 0.1058 to 0.2738), p = 0.0001. 
 
Figure 5.12 shows the 95% CI limit of the z-test results between neutered male and the 
spayed female dogs within the NMBM and the difference between the two proportions. 
 
 
Figure 5.12 The confidence limits of the results between the neutered male and the spayed 
female dogs in NMBM, and the difference between the two proportions 
 
The null hypothesis for the above two-proportions z-test is: 
 
H0: PNeutered Male = PSpayed Female 
 
The alternative hypothesis for the above two-proportions z-test is: 
 
HA: PNeutered Male ≠ PSpayed Female 
 
There was a statistical significant difference between the two independent binomial 
proportions (p < 0.05). Therefore, we can reject the null hypothesis and accept the alternative 
hypothesis (p = 0.0001). 
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5.3.1.3 Positive and negative results between male and female dogs 
Table 5.12 shows a cross-tabulation of the positive males/females and negative 
males/females within NMBM (PE). 
 
Table 5.12.15 B. canis results between the male and female dog population in NMBM 
(PE) 
Cross-tabulation 
Results 
Total 
Positive Negative 
Gender 
Male 
Count 18 184 202 
Expected count 19.7 182.3 202.0 
% within gender 8.91% 91.08% 100.0% 
Female 
Count 21 177 198 
Expected count 19.3 178.7 198.0 
% within gender 10.6% 89.39% 100.0% 
Total 
Count 39 361 400 
Expected count 39.0 361.0 400.0 
% within gender 9.75% 90.25% 100.0% 
 
Based on the calculations in Table 5.12, 202 male dogs and 198 female dogs were sampled 
in NMBM. The proportion of male dogs that were positive was 8.91% (18) and the 
proportion of dogs that were negative was 91.08% (184). The proportion of female dogs that 
were positive was 10.6% (21) and the proportion that were negative was 89.39% (177). The 
overall proportion of dogs that were positive for B. canis in the NMBM (PE) was 9.75% and 
the proportion that were negative for B. canis was 90.25%. 
 
The two-proportions z-test in Table 5.13 shows the comparison between the positive males 
and the positive females as well as the difference between the two proportions. 
 
Table 5.13.16 Z-test to compare between two proportions of the male and female, positive 
or negative dogs in the NMBM (PE) 
 Positive males Positive females Difference 
Mean (Sample 
proportion) 
0.0891 0.106 0.0169 
95% CI (asymptotic) 0.0498 – 0.1284 0.0631 – 0.1489 -0.0412 – 0.075 
Z – value 0.6   
P – value 0.5688   
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The z-test was performed between the male and female B. canis positive and negative results 
in NMBM (PE). The two-proportions z-test in Table 5.13 concludes that the male positive 
results (0.0891 (95% CI, 0.0498 to 0.1284)) was lower than the 0.106 (95% CI, 0.0631 to 
0.1489) positive results in the female dogs, and the difference in proportions was 0.0169 
(95% CI, -0.0412 to 0.075), p = 0.5688. 
 
Figure 5.13 shows the 95% CI limit of the z-test results between positive male and the 
positive female dogs in the NMBM and the difference between the two proportions. 
 
 
Figure 5.13 The confidence limits of the results between the positive male and the positive 
female dogs in the NMBM (PE), and the difference between the two proportions 
 
The null hypothesis for the above two-proportions z-test is: 
 
H0: PPositive Males = PPositive Females 
 
The alternative hypothesis for the above two-proportions z-test is: 
 
HA: PPositive Males ≠ PPositive Females 
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There was no statistically significant difference between the two independent binomial 
proportions (p > 0.05). Therefore, we cannot reject the null hypothesis and cannot accept the 
alternative hypothesis (p = 0.5688). 
 
5.3.1.4 B. canis positive and negative results in NMBM (PE) 
Figure 5.14 indicates the B. canis positive and negative results of all the study areas in 
NMBM (PE) 
 
Figure 5.14 Visual representation of the B. canis positive and negative proportions 
 
Based on the calculations in Table 5.14, 400 dogs were sampled in NMBM (PE). The 
proportion of dogs that were positive for B. canis in KwaZakhele was 10.0%, in Zwide 
16.0%, in New Brighton 10.0%, in KwaDwesi 5.1%, in Motherwell NU 29 8.9%, in 
Motherwell NU 13 15.0%, in Walmer 7.5%, in Save-A-Pet 10.0% and in the AACL 10.0%. 
The overall proportion of dogs that were positive for B. canis in the NMBM (PE) was 9.75% 
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and the proportion negative for B. canis was 90.25%. Both KwaMagaxki and the AWS (PE) 
had 0% positives. 
 
Table 5.14.17 B. canis results within all the areas surveyed in NMBM (PE) 
Cross-tabulation 
Results 
Total 
Positive Negative 
KwaZakhele 
Count 4 36 40 
Expected count 3.9 36.1 40.0 
% in townships and welfare organisations 10.0% 90.0% 100.0% 
Zwide 
Count 8 42 50 
Expected count 4.9 45.1 50.0 
% in townships and welfare organisations 16.0% 84.0% 100.0% 
New Brighton 
Count 4 36 40 
Expected count 3.9 36.1 40.0 
% in townships and welfare organisations 10.0% 90.0% 100.0% 
KwaMagaxki 
Count 0 20 20 
Expected count 2.0 18.1 20.0 
% in townships and welfare organisations 0.0% 100.0% 100.0% 
KwaDwesi 
Count 2 37 39 
Expected count 3.8 35.2 39.0 
% in townships and welfare organisations 5.1% 94.9% 100.0% 
Motherwell NU 29 
Count 6 55 61 
Expected count 5.9 55.1 61.0 
% in townships and welfare organisations 9.8% 90.2% 100.0% 
Motherwell NU 13 
Count 9 51 60 
Expected count 5.9 54.2 60.0 
% in townships and welfare organisations 15.0% 85.0% 100.0% 
Walmer 
Count 3 37 40 
Expected count 3.9 36.1 40.0 
% in townships and welfare organisations 7.5% 92.5% 100.0% 
Save-A-Pet 
Count 2 18 20 
Expected count 2.0 18.1 20.0 
% in townships and welfare organisations 10.0% 90.0% 100.0% 
AWS(PE) 
Count 0 20 20 
Expected count 2.0 18.1 20.0 
% in townships and welfare organisations 0.0% 100.0% 100.0% 
AACL 
Count 1 9 10 
Expected count 1.0 9.0 10.0 
% in townships and welfare organisations 10.0% 90.0% 100.0% 
Total 
Count 39 361 400 
Expected count 39.0 361.0 400.0 
% in townships and welfare organisations 9.75% 90.25% 100.0% 
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5.4 Townships of Nelson Mandela Bay Metropolitan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15 Visual presentation of the differences in the frequencies or percentages of the 
categories within the townships of NMBM 
 
The above presentation is classified into four groups subjected to analysis within the survey 
conducted. Results are recorded as true results, due to the fact that the true dog population 
sample size in the study area was known. The variables used for statistical analysis are the 
gender, neutered or spayed dogs, and positive and negative results of B. canis infection in 
the township of NMBM (PE).  
 
The gender result is true results of the male and female dog relation in the townships of 
NMBM. The sampling was not gender specific in each area. According to the survey, the 
350 dogs sampled in the townships consisted of 52% (182) males and 48% (168) females.  
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The neutered/spayed results provide the total number of male and female dogs sampled that 
have been neutered or spayed. As the results show, only 21% (73) of the dogs have been 
neutered or spayed and 79% (277) have not been neutered or spayed in the survey area.  
 
The BCS showed that the general condition score of the dogs in the township area is ideal 
(BCS 3). Only 1.4% (5) of the dogs were assessed as being emaciated with a BCS of 1, 29% 
(102) of the dogs were assessed as being thin with a BCS of 2, 66% (231) of the dogs were 
an ideal BCS of 3 and 32% (12) of the dogs were assessed at being overweight with a BCS 
of 4. 
   
The B. canis positive and negative results of the townships show the proportions between 
the number of dogs that tested either positive or negative for B. canis. The results used were 
a combination of the TAT and CFT. Overall positive results were 10.28% (36) and the 
negative results were 89.72% (314). 
 
KwaMagxaki and Walmer Townships were two of the townships that stood out from the 
other townships. In KwaMagxaki the gender relation was 80% male and 20% female, 95% 
of the dogs were neutered or spayed and 5% were not neutered or spayed. Only 50% of the 
dogs was of medium size and they had an average of 95% with a BCS of 3. The biggest 
difference between KwaMagxaki and the other townships were the fact that KwaMagxaki 
had no positive reactors for B. canis. In contrast to all the other townships, the biggest 
difference of Walmer was that 77% of the dogs were neutered or spayed, had an average of 
95% with a BCS of 3, but still had a prevalence of 7.5%. This clearly proves that even if the 
dogs are neutered or spayed and in good health, all dogs have an equal risk of becoming 
infected with B. canis.   
 
5.4.1 Test of two proportions 
The two-proportions z-test in Table 5.15 shows the comparison between the positive dogs 
and negative dogs as well as the difference between the two proportions. 
 
All statistical analysis was conducted by using the Laerd Statistics (SPSS) program.  
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Table 5.15.18 Z-test to compare the two proportions of the negative and positive dogs in 
the townships on NMBM (PE) 
 Positive Negative Difference 
Mean (Sample proportion) 0.1028 0.8971 0.7943 
95% CI (asymptotic) 0.071 – 0.1346 0.8653 – 0.9289 0.7202 – 0.2738 
Z – value 21   
P – value 0.00   
 
The z-test of the two proportions was performed between the positive and negative dogs in 
the townships of NMBM (PE). The two-proportions z-test in Table 5.15 leads to the 
conclusion that the positive results, 0.1028 (95% CI, 0.071 to 0.1346) was lower than the 
0.8971 (95% CI, 0.8653 to 0.9289) negative results in the townships, and the difference in 
proportions is 0.7943 (95% CI, 0.7202 to 0.2738), p = 0.00. 
 
Figure 5.16 shows the 95% CI limit of the z-test results positive and negative dogs in the 
townships and the difference between the two proportions. 
 
 
Figure 5.16 The confidence limits of the results between the positive and negative dogs in 
the townships and the difference between the two proportions 
 
The null hypothesis for the above two-proportions z-test is: 
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The alternative hypothesis for the above two-proportions z-test is: 
 
HA: PPositive ≠ PNegative 
 
There was a statistically significant difference between the two independent binomial 
proportions (p < 0.05). Therefore, we can reject the null hypothesis that the sample 
proportions are equal and accept the alternative hypothesis. p = 0.00 
 
5.5 Welfare organisations of the Nelson Mandela Bay Metropolitan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.17 Visual presentation of the differences in the frequencies (counts) or 
percentages of the categories in the welfare organisations of NMBM 
 
The above presentation is classified into four groups subjected to analysis within the survey 
conducted. Results are recorded as true results, due to the fact that the true dog population 
sample size in the study area was known. The variables used for statistical analysis are the 
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gender, neutered or spayed dogs, and positive and negative results of B. canis infection in 
the welfare organisations of NMBM (PE).  
 
The gender result is the male and female relation in the welfare organisation in NMBM. The 
sampling was not gender specific in each area. According to the survey, out of the dogs 
sampled 40% (20) were males and 60% (30) were females.  
 
The neutered/spayed results provide the total number of male and female dogs sampled that 
have been either neutered or spayed. As the results show, only 46% (23) of the dogs have 
been neutered or spayed and 54% (27) have not been neutered or spayed in the survey area.  
 
The BCS showed that the general condition score of the dogs in the welfare organisations is 
ideal (BCS 3). The proportion of BCS 2 dropped from 29% in the townships to only 10% in 
the welfare organisations. A proportion of 64% (32) dogs was assessed as being ideal with 
a BCS of 3, 24% (12) dogs were overweight with a BCS of 4 and 2% (1) dogs were assessed 
as being obese with a BCS of 5. 
 
The B. canis positive and negative results of the welfare organisations in NMBM (PE) 
indicate the proportions of the number of dogs that tested positive or negative for B. canis. 
The results used were a combination of the TAT and CFT. Overall positive results were 6% 
(3) and the negative results were 94% (47). 
 
It is of great concern that 30% of the dogs sampled at Save-A-Pet reacted to the first test, 
but only 10% tested positive with the 2ME-TAT. This could give rise to the possibility that 
the rest of the reactors at Save-A-Pet were not actively infected during that time. 
Furthermore, all the kennels at Save-A-Pet were shared kennels, indicating that the dogs that 
tested positive have most likely infected the other dogs sharing the kennel with them.  
In regards to this, all the dogs residing in the kennels at any welfare organisation should be 
properly tested for the B. canis antigen. All the dogs that tests positive should be kept 
separately and away from all the other animals. Before any dog is re-homed or adopted the 
dog must test negative for B. canis and a certificate stating that the dog tested negative should 
be provided to the new owner of the dog. 
 
 78 
 
5.5.1 Test of two proportions 
The two-proportions z-test in Table 5.16 shows the comparison between the positive dogs 
and the negative dogs as well as the difference between the two proportions. 
 
All statistical analysis was conducted by using the Laerd Statistics (SPSS) program.  
 
Table 5.16.19 Z-test to compare the two proportions of the negative and positive dogs in 
the welfare organisations in NMBM (PE) 
 Positive Negative Difference 
Mean (Sample proportion) 0.06 0.94 0.88 
95% CI (asymptotic) -0.0058 – 0.1258 0.8742 – 1.0058 0.684 – 1.076 
Z – value 8.8   
P – value 0.000   
 
The z-test was performed between B. canis positive and negative results of the welfare 
organisations in NMBM (PE). The two-proportions z-test in Table 5.16 concludes that the 
positive results, 0.06 (95% CI, -0.0058 to 0.1258) was lower than the 0.94 (95% CI, 0.8742 
to 1.0058) negative results in dogs, the difference in proportions is 0.88 (95% CI, 0.684 to 
1.076), p = 0.00 
 
Figure 5.18 shows the 95% CI limit of the z-test results of positive and negative dogs in the 
welfare organisations and the difference between the two proportions. 
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Figure 5.18 The confidence limits of the results between the positive and negative dogs in 
the welfare organisations and the difference between the two proportions 
 
The null hypothesis for the above two-proportions z-test is: 
 
H0: PPositive = PNegative  
 
The alternative hypothesis for the above two-proportions z-test is: 
 
HA: PPositive ≠ PNegative 
 
There was a statistically significant difference between the two independent binomial 
proportions (p < 0.05). Therefore, we can reject the null hypothesis and accept the alternative 
hypothesis that the sample proportions are equal (p = 0.00) 
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CHAPTER 6 
CONCLUSION AND RECOMMENDATIONS 
 
The four objectives set for this study have been met and the results recorded. Data collected 
from serological tests conducted on 400 sera samples were processed and the estimated 
prevalence for each area was established.  
 
The results obtained from the study conducted in NMBM (PE) in the Eastern Cape indicates 
that B. canis is indeed endemic in South Africa  
 
The townships in NMBM (PE) had a higher prevalence rate of B. canis as compared to the 
welfare organisations, mostly due to the free roaming and/or uncontrolled dogs in the 
townships. When comparing the townships, KwaMagxaki is an upper-class township and 
had no free roaming or uncontrolled dogs resulting in a prevalence rate of  0% as opposed 
to Zwide with a prevalence of 16%. It is therefore evident that B. canis is present mostly in 
the townships with the potential of spreading through uncontrolled and free roaming dogs, 
without the owners’ knowledge. In regards to the general status of the dogs’ that are positive 
for B. canis, the results clearly indicate that even if the dogs are neutered or spayed and in 
good health, all dogs have an equal risk of becoming infected with B. canis. 
 
Similar results have been found in studies conducted in the Southern States (USA) (Greene 
et al., 2006) and in Quebec, Canada (Chikweto et al., 2013; Fredrickson & Barton 1974; 
Lovejoy et al., 1976) where stray or free roaming dogs have higher prevalence rates 
compared to owned or controlled dogs. In the Mediterranean area, it was also stated that 
stray dogs serve as a reservoir for B. canis (Araz et al., 2010). 
 
The prevalence rate in NMBM (PE) was 9.75% with almost the same results as the Fars 
Province in Iran with a prevalence of 10.62%. The only difference being that in PE the 
majority of infected dogs were mixed breeds from the townships, but result in the Fars 
Province indicated that all the exotic breeds was infected with B. canis (Behzadi & 
Mogheiseh, 2011). However, in the endemic area of the Fars Province, stray dogs were still 
indicated as the source of infection (Mohammad et al., 2002). 
 
 81 
 
During the survey study in NMBM (PE), it was evident that a broader survey should be 
conducted over the whole NMBM (PE) and not just the townships and welfare organisations. 
Surveys up to Uitenhage should be able to determine how far and how severe B. canis has 
already spread inland. Preventive measures against this contagion should be taken to 
eliminate B. canis infection from the entire dog population and reservoir dogs should either 
be kept in quarantine or euthanized 
 
Most of the dog owners did not know that the diseases existed and/or that B. canis infection 
is present in South Africa. Animal health care professionals, dog owners and breeders need 
to be informed that B. canis is indeed in South Africa and of the consequences involved. 
The fact that B. canis is a zoonotic disease, actively infected and reservoir dogs are and will 
always be a risk to human health. 
 
. 
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ANNEXURES 
Annexure A:  Brucella canis positive dogs within the NMBM  
 
Brucella canis positive dogs 
Sample 
Number 
Breed 
Size 
Gender Sterilized BCS 
Total 
dogs 
2 Medium M N 3 1 
8 Medium M N 2 4 
29 Medium F N 2 1 
39 Medium M N 2 2 
45 Large M N 3 3 
54 Medium M N 3 1 
62 Large M N 2 2 
67 Large F N 4 2 
77 Medium F N 3 3 
80 Medium F N 2 1 
81 Small F N 4 1 
87 Medium F N 2 3 
100 Medium M N 3 1 
101 Medium M Y 3 2 
111 Small M N 2 2 
115 Small F N 2 1 
155 Large F N 3 3 
163 Medium M N 3 3 
198 Medium F N 3 2 
199 Medium F N 3 2 
200 Medium F N 3 3 
208 Small F Y 2 1 
210 Medium M N 2 2 
234 Medium F N 3 1 
257 Medium F N 3 3 
271 Large M N 3 1 
273 Medium M N 3 1 
280 Medium M N 3 2 
287 Medium F N 3 1 
299 Medium M N 3 2 
301 Medium F N 3 1 
303 Medium M N 3 1 
305 Medium F N 3 2 
315 Medium F Y 3 N/A 
326 Medium F Y 4 N/A 
371 Medium F Y 3 2 
373 Medium M Y 3 2 
383 Medium F Y 3 1 
396 Medium M N 3 4 
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Annexure B:  Sera samples reacting to Brucella canis antigen in the TAT 
 
Reactors to Brucella canis antigen 
Sample 
Number 
Breed 
Size 
Gender Sterilized BCS 
Total 
dogs 
2 Medium M N 3 1 
8 Medium M N 2 4 
29 Medium F N 2 1 
38 Medium M N 2 2 
39 Medium M N 2 2 
45 Large M N 3 3 
51 Medium M N 3 1 
54 Medium M N 3 1 
56 Medium F N 4 1 
62 Large M N 2 2 
67 Large F N 4 2 
74 Medium M Y 2 1 
76 Medium F N 2 2 
77 Medium F N 3 3 
80 Medium F N 2 1 
81 Small F N 4 1 
84 Medium F N 2 1 
87 Medium F N 2 3 
100 Medium M N 3 1 
101 Medium M Y 3 2 
111 Small M N 2 2 
115 Small F N 2 1 
120 Medium F Y 4 1 
143 Small M N 3 1 
155 Large F N 3 3 
163 Medium M N 3 3 
198 Medium F N 3 2 
199 Medium F N 3 2 
200 Medium F N 3 3 
208 Small F Y 2 1 
210 Medium M N 2 2 
234 Medium F N 3 1 
235 Medium F N 3 1 
243 Medium F N 3 1 
257 Medium F N 3 3 
268 Medium F Y 3 1 
271 Large M N 3 1 
273 Medium M N 3 1 
280 Medium M N 3 2 
282 Medium M N 2 1 
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Reactors to Brucella canis antigen (continued) 
Sample 
Number 
Breed 
Size 
Gender Sterilized BCS 
Total 
dogs 
285 Large M N 3 2 
294 Medium M N 3 1 
299 Medium M N 3 2 
301 Medium F N 3 1 
302 Medium M N 3 1 
303 Medium M N 3 1 
304 Medium F N 3 1 
305 Medium F N 3 2 
306 Small M N 2 2 
311 Medium F Y 4 N/A 
312 Medium F Y 3 N/A 
315 Medium F Y 3 N/A 
317 Medium F Y 3 N/A 
318 Small F Y 3 N/A 
326 Medium F Y 4 N/A 
357 Medium F Y 3 1 
371 Medium F Y 3 2 
372 Large M Y 3 2 
373 Medium M Y 3 2 
383 Medium F Y 3 1 
396 Medium M N 3 4 
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Annexure C:  Data from questionnaires 
 
KwaZakhele Township 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
1 Medium M N 18 3 Slight 1 
2 Medium M N 48 3 None 1 
3 Medium M N 36 2 None 1 
4 Medium M N 24 2 Slight 1 
5 Small M N 8 2 None 1 
6 Small M N 24 2 None 2 
7 Small M N 12 1 None 1 
8 Medium M N 60 2 Slight 4 
9 Medium M Y 60 2 None 3 
10 Medium F N 60 3 None 3 
11 Small M N 24 2 Slight 2 
12 Small M N 12 2 None 3 
13 Medium M N 36 2 None 3 
14 Medium M N 84 2 Slight 1 
15 Small M N 72 2 None 4 
16 Small M N 48 2 None 2 
17 Large F N 21 3 None 3 
18 Small M N 12 2 None 2 
19 Medium M N 30 2 None 1 
20 Small F N 24 2 None 1 
21 Medium M N 24 2 None 1 
22 Small F N 24 1 Mild 1 
23 Large M N 48 3 Slight 1 
24 Medium M N 27 3 Slight 2 
25 Small F N 20 3 None 1 
26 Medium F N 51 3 Slight 2 
27 Medium F N 36 2 Mild 1 
28 Medium M N 36 2 Slight 2 
29 Medium F N 48 2 Slight 1 
30 Medium F N 30 3 None 2 
31 Medium M N 36 3 None 2 
32 Medium F N 36 3 Slight 1 
33 Medium M N 60 2 Mild 2 
34 Medium M Y 72 3 None 2 
35 Medium M N 36 2 Mild 2 
36 Small F N 60 2 Slight 2 
37 Medium F N 36 2 Mild 2 
38 Medium M N 72 2 Mild 2 
39 Medium M N 48 2 Mild 2 
40 Small F N 30 2 Mild 1 
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Zwide Township 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
41 Small F Y 48 3 Slight 1 
42 Medium F N 60 2 Slight 2 
43 Medium F N 36 2 Slight 2 
44 Medium F N 108 3 Slight 3 
45 Large M N 24 3 None 3 
46 Large F Y 36 3 None 3 
47 Large M N 84 3 None 3 
48 Medium M N 9 3 Slight 1 
49 Medium M N 144 2 None 2 
50 Medium M Y 48 3 Slight 1 
51 Medium M N 110 3 Severe 1 
52 Medium F N 110 2 Mild 4 
53 Medium M Y 144 3 Slight 1 
54 Medium M N 12 3 Slight 1 
55 Large M N 12 3 Slight 2 
56 Medium F N 12 4 None 1 
57 Small F N 48 3 Severe 3 
58 Medium M N 36 2 Slight 1 
59 Large F N 8 3 Slight 1 
60 Medium M N 48 3 Slight 2 
61 Large F N 11 3 None 2 
62 Large M N 36 2 None 2 
63 Medium F Y 24 3 Slight 2 
64 Medium M N 24 2 Slight 2 
65 Medium F N 24 2 Slight 3 
66 Large M N 36 2 Slight 3 
67 Large F N 36 4 Slight 2 
68 Medium M N 16 2 Slight 1 
69 Medium M N 84 3 Slight 1 
70 Medium M N 108 2 Slight 1 
71 Medium F N 60 2 Slight 2 
72 Medium M N 220 2 None 1 
73 Small M N 28 2 Slight 1 
74 Medium M Y 96 2 Slight 1 
75 Medium M N 12 2 Slight 1 
76 Medium F N 36 2 Slight 2 
77 Medium F N 24 3 Slight 3 
78 Small F N 36 2 Severe 3 
79 Small F N 36 3 Severe 3 
80 Medium F N 48 2 Slight 1 
 
 
 103 
 
Zwide Township (continued) 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
81 Small F N 72 4 Slight 1 
82 Medium M N 60 3 Slight 2 
83 Medium M N 42 3 Slight 1 
84 Medium F N 60 2 Slight 1 
85 Small F N 121 3 Slight 1 
86 Medium F N 18 3 Slight 3 
87 Medium F N 60 2 Slight 3 
88 Medium M N 36 2 Slight 1 
89 Small F N 36 2 Slight 1 
90 Medium M N 48 3 Slight 1 
90 Medium M N 48 3 Slight 1 
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New Brighton Township 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
91 Medium F Y 48 4 Slight 1 
92 Medium F Y 36 3 Slight 4 
93 Medium F N 36 3 Slight 1 
94 Medium F N 84 3 Slight 1 
95 Medium F N 36 3 Slight 4 
96 Medium F Y 40 3 Slight 1 
97 Small F Y 12 2 Slight 1 
98 Small F N 36 2 Mild 1 
99 Small F N 54 3 None 1 
100 Medium M N 26 3 Slight 1 
101 Medium M Y 60 3 Slight 2 
102 Small F N 24 2 Slight 3 
103 Small F Y 30 2 Slight 3 
104 Small M N 17 2 Slight 3 
105 Medium F N 36 2 Slight 2 
106 Medium F Y 108 2 Severe 1 
107 Medium F N 24 2 Slight 1 
108 Medium M N 36 2 Slight 1 
109 Medium F N 72 3 Mild 1 
110 Medium M N 36 2 Slight 2 
111 Small M N 60 2 Slight 2 
112 Small F N 24 2 Slight 4 
113 Medium F Y 36 3 Slight 2 
114 Medium F N 24 1 Slight 4 
115 Small F N 36 2 Severe 1 
116 Medium F N 30 3 Slight 3 
117 Medium M N 24 3 None 1 
118 Medium M N 36 1 Mild 2 
119 Medium F Y 30 3 Slight 1 
120 Medium F Y 36 4 Slight 1 
121 Small F N 72 3 Slight 1 
122 Medium M Y 120 3 Slight 1 
123 Large M N 24 3 Slight 1 
124 Medium F N 48 3 Slight 3 
125 Medium F N 24 3 Slight 3 
126 Large M N 24 3 Slight 3 
127 Small F N 24 3 Slight 1 
128 Medium M N 24 1 Slight 2 
129 Small F N 36 2 Severe 1 
130 Medium M N 24 2 Slight 1 
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KwaMagxaki Township 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
131 Large M N 12 3 Slight 1 
132 Large M N 96 3 Slight 1 
133 Medium M N 11 3 Slight 1 
134 Large F N 12 3 Slight 1 
135 Medium M N 96 3 Slight 1 
136 Medium M N 12 3 Slight 1 
137 Small M N 132 3 None 2 
138 Small F Y 132 3 Slight 2 
139 Medium F N 12 2 Slight 1 
140 Small M N 48 3 None 1 
141 Medium M N 8 3 None 1 
142 Medium M N 12 3 Mild 2 
143 Small M N 24 3 Slight 1 
144 Medium M N 36 3 Slight 3 
145 Medium M N 36 3 Slight 2 
146 Medium M N 96 3 Slight 2 
147 Medium M N 18 3 Slight 1 
148 Large M N 8 3 Slight 2 
149 Large F N 12 3 Slight 2 
150 Large M N 72 3 Slight 2 
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KwaDwesi Township 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
151 Medium M N 36 2 Slight 3 
152 Medium F Y 102 3 Slight 3 
153 Medium M N 24 2 Slight 3 
154 Small F N 9 3 Slight 3 
155 Large F N 24 3 Slight 3 
156 Medium M N 132 2 Slight 3 
157 Medium F N 120 3 Slight 2 
158 Medium M N 24 3 Slight 1 
159 Medium M N 17 3 Slight 1 
160 Medium M Y 16 3 Slight 2 
161 Medium M N 24 3 Slight 1 
162 Medium M N 24 3 Slight 1 
163 Medium M N 144 3 Slight 3 
164 Medium M Y 60 3 Slight 3 
165 Medium F N 48 3 Slight 1 
166 Medium M N 8 2 Slight 1 
167 Medium F Y 192 3 Mild 3 
168 Small F N 8 3 Slight 1 
169 Medium F N 12 3 Slight 2 
171 Medium M N 24 3 Slight 1 
172 Large F N 36 3 Slight 2 
173 Medium M N 60 3 Slight 4 
174 Medium F N 12 3 Slight 4 
175 Medium M N 18 3 Slight 1 
176 Medium M N 12 3 Slight 1 
177 Medium F N 96 3 Slight 1 
178 Large M N 15 3 Slight 2 
179 Medium M N 36 3 Slight 2 
180 Medium M N 18 3 Slight 1 
181 Large F Y 48 2 Slight 2 
182 Medium M N 96 3 Mild 1 
183 Medium F Y 60 3 Slight 3 
184 Large F Y 48 3 Slight 2 
185 Large M Y 24 3 Slight 2 
186 Medium F Y 24 3 Slight 3 
187 Small M Y 48 3 Slight 3 
188 Small F Y 36 3 Slight 3 
189 Large M N 96 3 Slight 1 
190 Medium F N 36 3 Slight 2 
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Motherwell NU 29 Township 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
170 Medium M N 72 3 Slight 1 
191 Small F N 8 2 Slight 1 
192 Medium F N 36 3 Slight 1 
193 Medium F N 24 2 Slight 1 
194 Small M N 60 2 Slight 1 
195 Medium F N 24 2 Slight 1 
196 Medium F N 108 2 Slight 1 
197 Medium M N 10 3 Slight 2 
198 Medium F N 84 3 Slight 2 
199 Medium F N 10 3 Slight 2 
200 Medium F N 77 3 Slight 3 
201 Medium M N 66 3 Slight 1 
202 Medium M N 72 3 Slight 1 
203 Medium F Y 48 3 Slight 1 
204 Medium M N 24 3 Slight 3 
205 Small F N 132 2 Slight 3 
206 Medium M N 24 3 Slight 3 
207 Medium M N 48 3 Slight 1 
208 Small F Y 24 2 Slight 1 
209 Medium M N 24 3 Slight 2 
210 Medium M N 72 2 Slight 2 
211 Small F N 36 2 Slight 2 
212 Medium M N 72 3 Slight 1 
213 Medium F N 36 3 Slight 1 
214 Medium M N 42 3 Slight 1 
215 Medium F N 72 2 Slight 1 
216 Medium M N 48 3 Slight 5 
217 Medium M N 72 3 Slight 5 
218 Medium M N 48 2 Slight 1 
219 Large M N 60 3 Slight 1 
220 Medium M N 72 3 Slight 2 
221 Small M N 60 2 Slight 1 
222 Medium M N 120 3 Slight 1 
223 Medium M N 192 2 Slight 3 
224 Medium M N 24 2 Slight 2 
225 Small M N 24 2 Slight 3 
226 Medium M N 192 3 Slight 3 
227 Small F N 144 2 Slight 2 
228 Medium M N 36 2 Slight 2 
229 Medium M N 48 3 Slight 1 
230 Medium F N 36 3 Slight 1 
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Motherwell NU 29 Township (continued) 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
231 Small F N 12 2 Slight 1 
232 Large M N 60 3 Slight 1 
233 Medium F N 12 3 Slight 1 
234 Medium F N 48 3 Slight 1 
235 Medium F N 48 3 Slight 1 
236 Small F N 24 3 Slight 2 
237 Medium M N 84 3 Severe 1 
238 Medium F N 72 3 Slight 2 
239 Medium M N 24 3 Slight 3 
240 Medium M N 72 3 Slight 1 
241 Medium M N 36 2 Slight 3 
242 Medium M N 36 3 Slight 1 
243 Medium F N 120 3 Slight 1 
244 Large F N 8 3 Slight 1 
245 Small M N 48 2 Slight 1 
246 Small F N 48 3 Slight 4 
247 Small F N 96 2 Slight 1 
248 Medium F N 36 3 Slight 1 
249 Medium F N 12 2 Slight 1 
250 Large F N 72 4 Slight 1 
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Motherwell NU 13 Township 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
251 Small F N 84 3 Mild 2 
252 Medium M N 96 3 Slight 1 
253 Medium M N 60 3 Slight 2 
254 Small F N 48 3 Mild 2 
255 Medium M N 30 3 Slight 2 
256 Medium M N 24 3 Slight 3 
257 Medium F N 24 3 Severe 3 
258 Medium M N 24 3 Slight 2 
259 Medium M N 12 3 Mild 1 
260 Medium M N 24 3 Slight 1 
261 Medium M N 24 3 Slight 1 
262 Medium M N 36 4 Slight 1 
263 Medium M N 18 3 Slight 1 
264 Large M N 24 3 Slight 1 
265 Medium F N 36 3 Slight 1 
266 Medium F N 24 2 Slight 2 
267 Medium F N 36 3 Slight 2 
268 Medium F Y 60 3 Slight 1 
269 Medium M N 12 3 Slight 2 
270 Small F N 60 3 Slight 1 
271 Large M N 60 3 Slight 1 
272 Medium F N 42 3 Slight 1 
273 Medium M N 48 3 Slight 1 
274 Medium F Y 48 4 Slight 2 
275 Medium M N 30 3 Slight 2 
276 Medium M N 36 3 Slight 2 
277 Medium F N 48 2 Slight 1 
278 Small F N 48 2 Slight 2 
279 Medium F Y 60 4 Slight 1 
280 Medium M N 20 3 Slight 2 
281 Small F N 60 2 Slight 1 
282 Medium M N 84 2 Mild 1 
283 Medium M N 48 2 Slight 1 
284 Medium F N 12 3 Slight 1 
285 Large M N 18 3 Slight 2 
286 Medium M N 24 2 Slight 2 
287 Medium F N 24 3 Slight 1 
288 Medium F Y 48 3 Slight 2 
289 Large M N 84 2 Slight 2 
290 Large M N 24 3 Slight 3 
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Motherwell NU 13 Township (continued) 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
Dogs 
291 Small F Y 121 2 Slight 2 
292 Medium M N 36 2 Slight 1 
293 Large F Y 108 3 Slight 1 
294 Medium M N 24 3 Slight 1 
295 Medium F Y 24 3 Slight 1 
296 Medium M N 12 3 Slight 2 
297 Medium F N 12 3 Slight 3 
298 Medium F N 72 4 Slight 1 
299 Medium M N 36 3 Slight 2 
300 Medium M N 24 2 Slight 2 
301 Medium F N 84 3 Slight 1 
302 Medium M N 48 3 Slight 1 
303 Medium M N 12 3 Slight 1 
304 Medium F N 36 3 Slight 1 
305 Medium F N 84 3 Slight 2 
306 Small M N 120 2 Slight 2 
307 Small F N 36 4 Slight 1 
308 Medium F N 12 3 Slight 2 
309 Medium F N 18 3 Slight 2 
310 Medium M N 24 3 Slight 2 
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Save-A-Pet Rehabilitation Centre 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
311 Medium F Y 108 4 None N/A 
312 Medium F Y 48 3 None N/A 
313 Medium M Y 24 3 None N/A 
314 Medium M Y 48 3 None N/A 
315 Medium F Y 18 3 None N/A 
316 Medium M Y 96 3 None N/A 
317 Medium F Y 48 3 None N/A 
318 Small F Y 12 3 None N/A 
319 Medium F Y 24 4 None N/A 
320 Medium F Y 42 3 None N/A 
321 Medium F Y 24 4 None N/A 
322 Medium M Y 48 4 None N/A 
323 Medium M Y 12 3 None N/A 
324 Medium F Y 91 3 None N/A 
325 Medium F Y 72 4 None N/A 
326 Medium F Y 54 4 None N/A 
327 Medium F Y 108 5 None N/A 
328 Medium F Y 36 3 None N/A 
329 Medium M Y 72 3 None N/A 
330 Medium F Y 72 4 None N/A 
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Animal Welfare Society Port Elizabeth 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
331 Medium F Y N/A 2 None N/A 
332 Medium F Unknown N/A 4 None N/A 
333 Large M Y N/A 3 None N/A 
334 Medium M N N/A 3 None N/A 
335 Large M N N/A 3 None N/A 
336 Medium M Y N/A 3 None N/A 
337 Large M N N/A 3 None N/A 
338 Medium M N N/A 2 None N/A 
339 Medium M N N/A 3 None N/A 
340 Medium M N N/A 2 None N/A 
341 Medium F N N/A 3 None N/A 
342 Large M N N/A 3 None N/A 
343 Large M N N/A 3 None N/A 
344 Medium F Unknown N/A 3 None N/A 
345 Medium F Unknown N/A 3 None N/A 
346 Medium M Y N/A 3 None N/A 
347 Large F N N/A 3 None N/A 
348 Medium F Unknown N/A 3 None N/A 
349 Medium F N N/A 3 None N/A 
350 Large F Unknown N/A 3 None N/A 
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Walmer Township 
Sample 
Number 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
351 Medium M N 36 3 Slight 2 
352 Medium M N 36 3 Slight 2 
353 Large F Y 9 3 Slight 1 
354 Medium F Y 24 3 Slight 2 
355 Medium F N 24 3 Slight 2 
356 Large F Y 24 3 Slight 1 
357 Medium F Y 36 3 Slight 1 
358 Medium M N 36 3 Slight 3 
359 Medium F Y 18 3 Slight 3 
360 Medium F N 24 3 Slight 1 
361 Medium M Y 24 3 Slight 3 
362 Medium F Y 18 3 Slight 3 
363 Small F N 12 3 Mild 1 
364 Large M Y 36 3 Slight 2 
365 Medium F Y 36 3 Slight 1 
366 Large M Y 72 3 Slight 1 
367 Medium F Y 36 3 Slight 2 
368 Large F Y 30 4 Slight 4 
369 Small F Y 12 3 Slight 2 
370 Medium M N 36 3 Slight 1 
371 Medium F Y 48 3 Slight 2 
372 Large M Y 60 3 Slight 2 
373 Medium M Y 102 3 Slight 2 
374 Medium F Y 24 3 Slight 2 
375 Large M Y 72 3 Slight 2 
376 Medium M Y 24 3 Slight 2 
377 Small M Y 10 3 Slight 1 
378 Medium F N 14 3 Slight 1 
379 Medium F Y 72 3 Slight 2 
380 Medium F Y 84 3 Slight 4 
381 Small f y 48 2 Slight 1 
382 Medium F Y 72 3 Slight 4 
383 Medium F Y 120 3 Slight 1 
384 Medium F Y 8 3 Slight 4 
385 Medium F Y 48 3 Slight 2 
386 Medium F Y 8 3 Slight 4 
387 Large M Y 84 3 Slight 2 
388 Medium M N 8 3 Slight 1 
389 Small M Y 72 3 Slight 1 
390 Large F Y 120 3 Slight 2 
390 Large F Y 120 3 Slight 2 
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Animal Anti Cruelty League 
Sample 
NUMBE
R 
Breed 
Size 
Gender Sterilized 
Age 
(Mth) 
BCS Ext. Par. 
Total 
dogs 
391 Medium M N N/A 2 Severe N/A 
392 Medium F N N/A 3 Slight 4 
393 Medium F N N/A 3 Slight 4 
394 Medium F N N/A 3 Slight 4 
395 Medium M N N/A 4 Slight 1 
396 Medium M N N/A 3 Slight 4 
397 Medium F N N/A 4 None 1 
398 Small F N N/A 2 None 1 
399 Medium F N N/A 4 None 1 
400 Medium F N N/A 4 Mild 1 
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